# 16 医学文献  16 The medical literature  

人们确实觉得，统计技术，无论是设计还是分析，有时更像是一种仪式，旨在安抚那些拥有绝对权力的人（期刊编辑），或许还有监管机构，而不是因为这些技术被认为具有科学重要性。  
One does feel that statistical techniques both of design and analysis are sometimes adopted rather as rituals designed to assuage the last holders of absolute power (editors of journals) and perhaps also regulatory agencies, and not because the techniques are appreciated to be scientifically important.  

Cox (1983)  
Cox (1983)  

## 16.1 引言  16.1 INTRODUCTION  

本世纪以来，临床研究及其对临床实践的影响都取得了巨大的发展。研究成果的发表，尤其是在顶级期刊上发表，能够迅速将这些发现传播到世界各地。一篇在同行评审期刊上发表的论文意味着该研究既科学严谨又具有临床价值—它赋予了这项工作可信度和受人尊敬的地位。如果所有发表的论文都科学严谨，那当然很好，但遗憾的是，从统计学的角度来看，研究水平仍有许多不足之处。几乎任何医学期刊的任何一期中，都能看到设计不规范和分析不正确的例子。  
During this century clinical research has grown enormously as has its influence on clinical practice. Publication of research results, especially in a leading journal, will rapidly disseminate those findings all over the world. A paper in a peer- reviewed journal implies that the research is both scientifically sound and clinically worthwhile - it bestows both credibility and respectability on the work. This would be fine if all published papers were scientifically sound but, regrettably, the standard of research leaves much to be desired from the statistical point of view. Examples of substandard design and incorrect analysis can be seen in almost any issue of any medical journal.  

健全的设计和分析的重要性再怎么强调也不为过。显然，一项研究的结论必须依赖于方法的正确性。如果由于方法学上的缺陷导致结论不可靠，那么这项研究就不可能具有临床价值。更糟糕的是，它可能因为结论具有误导性而对临床造成危害，而一项对临床有害的研究无疑是不道德的。  
The importance of sound design and analysis cannot be overemphasized. Clearly the conclusions from a study must rely on the methods having been correct. If the conclusions are unreliable because of faulty methodology, then the study cannot be clinically worthwhile. Worse, it may be clinically harmful by reason of the conclusions being misleading, and a clinically harmful study is surely unethical.  

因此，在1980年，我有些犹豫地提出滥用统计学是不道德的（Altman, 1982a），这一观点后来得到了广泛认同，但从未受到挑战。不合标准的研究（不仅仅是统计错误）的伦理影响包括：  
Thus, with some diffidence, in 1980 I suggested that the misuse of statistics was unethical (Altman, 1982a), a view which has subsequently been widely endorsed but never challenged. The ethical implications of substandard research (not just statistical errors) are:  

1. 滥用患者，使其面临不合理的风险和不便；   
1. the misuse of patients by exposing them to unjustified risk and inconvenience;   
2. 滥用资源，包括研究人员的时间，这些时间本可以更好地用于更有价值的活动；以及  
2. the misuse of resources, including the researchers' time, which could be better employed on more valuable activities; and  
3. 发布误导性结果的后果，其中可能包括进行不必要的后续工作。  
3. the consequences of publishing misleading results, which may include the carrying out of unnecessary further work.  

在极端情况下，这可能对患者护理产生直接影响。特别是，有几个例子表明，某些治疗方法在非对照研究中显示出有希望的结果后被广泛使用，但后来随机对照试验表明它们是无效的（参见第15.2.1节）。同样，流行病学研究中相互矛盾的结果可能与方法学差异有关。  
In the extreme there may be a direct effect on patient care. In particular, there have been several examples of treatments that were widely used on the basis of promising results from uncontrolled studies, but were later shown by randomized trials to be ineffective (see section 15.2.1). Likewise, conflicting results from epidemiological studies may relate to methodological differences.  

这些评论引出了三个不可避免的结论。首先，研究人员在规划、执行、分析和解释研究时应格外小心。其次，在阅读和解释其他可能忽视了第一点的研究者的研究结果时，也需要谨慎。正如 Albert（1981）所说：“医生最重要的技能之一是批判性分析医学文献中原创贡献的能力。”第三，已发表论文中统计学的标准可能受到医学期刊编辑和审稿政策的影响。  
These remarks lead to three inevitable conclusions. First it behoves the researcher to take the greatest care in planning, executing, analysing and interpreting research. Second, care is needed too in reading and interpret. ing the research results from other investigators who may have disregarded the first point. As Albert (1981) has said: 'One of the most important skills a physician should have is the ability to critically analyse original contributions to the medical literature.' Third, the standard of statistics in published papers can be influenced by the editorial and refereeing policy of medical journals.  

在本章的最后一章中，我将简要回顾统计学在医学研究中的发展，总结已发表论文中统计质量的评估结果，探讨医学期刊在提高质量方面的作用，并就阅读和撰写科学论文提供指导。  
In this final chapter I shall briefly consider the growth of statistics within medical research, summarize the findings of reviews of the quality of statistics in published papers, consider the role of medical journals in improving the quality, and give guidance on reading and writing scientific papers.  

## 16.2 医学研究中统计学的发展  16.2 THE GROWTH OF STATISTICS IN MEDICAL RESEARCH  

我们无法精确指出统计方法何时引入医学研究，但除了少数显著例外，我们可以追溯到本世纪的第一个季度。1929年，一篇巨大学术论文发表在一家生理学期刊上，阐述了统计分析和解释的许多主要原则（Dunn, 1929）。到1937年，统计方法在临床研究中的正确使用被认为足够重要，以至于《柳叶刀》杂志发表了奥斯汀·布拉德福德·希尔（Austin Bradford Hill）撰写的15篇关于统计方法的系列文章。这些文章很快以书籍形式再版；这本有影响力的书在50年后仍在印刷（Hill, 1984），这证明了它的质量。  
It is not possible to pinpoint the introduction of statistical methods into medical research, but with a few notable exceptions we may look to the first quarter of this century. In 1929 a huge paper was published in a physiology journal expounding many of the main principles of statistical analysis and interpretation (Dunn, 1929). By 1937 the correct use of statistical methods in clinical research was considered important enough for the Lancet to publish a series of 15 articles on statistical methods by Austin Bradford Hill. These were quickly republished in book form; that this influential book remains in print 50 years later (Hill, 1984) pays tribute to its quality.  

我们可以将医学统计学的现代兴起视为始于1937年或1948年，当时第一项著名的随机临床试验报告发表。这是医学研究委员会关于链霉素治疗肺结核的试验（Medical Research Council, 1948），其中布拉德福德·希尔是关键影响人物。然而，总的来说，统计学引入医学研究的过程是缓慢的。1954年，《英国医学杂志》报道了皇家统计学会“医学统计学研究小组”举行的一场辩论（Anon, 1954）。动议是“本院应欢迎统计学在医学所有分支中日益增长的影响”。动议的反方提出了一个引人注目的观点，即医学是一门艺术，统计学是一门科学，因此统计学在医学中是不合时宜的。更令人惊讶的是，考虑到论坛的性质，该动议仅以微弱多数通过。  
We might consider the modern rise of medical statistics to start either in 1937 or in 1948, when the report of the first well known randomized clinical trial was published. This was the Medical Research Council trial of streptomycin for pulmonary tuberculosis (Medical Research Council, 1948), in which Bradford Hill was a key influence. However, in general the introduction of statistics into medical research was slow. In 1954 the British Medical Journal reported a debate held by the Royal Statistical Society's 'Study Circle on Medical Statistics' (Anon, 1954). The motion was 'This house should welcome the growing influence of statistics in all branches of medicine'. The opposite of the motion made the remarkable observation that medicine was an art and statistics was a science, so statistics was out of place in medicine. More surprising, considering the forum, is that the motion was carried by only a narrow majority.  

自1954年以来，发生了许多变化，统计方法现已牢固地扎根于医学领域。通过对《儿科学》杂志在1952年、1962年、1972年和1982年发表的论文进行研究（Hayden, 1983），可以很好地了解统计学的发展。如表16.1所示，使用统计分析方法的论文比例大幅增加，并且使用超出简单 $t$ 和 $\chi^{2}$ 检验以及相关性方法的情况增加了十倍。后者的变化在1972年至1982年间尤为显著。对《新英格兰医学杂志》的类似研究表明，1978-79年发表的论文中，有 $45\%$ 的论文仅使用了简单的统计分析方法（Colditz and Emerson, 1985）。另一项研究对比了1967-68年和1982年发表在《关节炎与风湿病》杂志上的论文中的统计分析（Felson et al., 1984）。如表16.2所示，他们发现这两个时期之间存在一些显著变化。1982年发表的论文包含更多的统计分析，这可能至少部分归因于计算机的普及。包含统计错误的论文比例大致相同，但错误的性质发生了显著变化。  
Much has happened since 1954, and statistical methods are now firmly entrenched in medicine. A good idea of the growth of statistics is given by a study of papers published by the journal Pediatrics in the years 1952, 1962, 1972 and 1982 (Hayden, 1983). As Table 16.1 shows, there was a large increase in the proportion of papers using statistical methods of analysis and a ten fold rise in the use of methods beyond simple  $t$  and  $\chi^{2}$  tests and correlation. The change in the latter was especially marked between 1972 and 1982. A similar study of the New England Journal of Medicine showed that  $45\%$  of papers published in 1978- 79 used only simple methods of statistical analysis (Colditz and Emerson, 1985). Another study contrasted the statistical analyses in papers published in Arthritis and Rheumatism in 1967- 68 and 1982 (Felson et al., 1984). As Table 16.2 shows, they found some marked changes between the two periods. Papers published in 1982 contained many more statistical analyses, which may be at least partly due to the availability of computers. The proportion of papers containing statistical errors was much the same, but the nature of the errors had changed considerably.  

表16.1 《儿科学》杂志中统计程序的使用情况（Hayden, 1983）  
Table 16.1 Use of statistical procedures in Pediatrics (Hayden, 1983)  

<table><tr><td rowspan="2"></td><td colspan="4">年份</td></tr><tr><td>1952</td><td>1962</td><td>1972</td><td>1982</td></tr><tr><td>论文数量</td><td>67</td><td>98</td><td>115</td><td>151</td></tr><tr><td>无统计程序</td><td>66%</td><td>59%</td><td>45%</td><td>30%</td></tr><tr><td>除t、χ²和r之外的统计程序</td><td>3%</td><td>5%</td><td>12%</td><td>35%</td></tr></table>  
<table><tr><td rowspan="2"></td><td colspan="4">Year</td></tr><tr><td>1952</td><td>1962</td><td>1972</td><td>1982</td></tr><tr><td>Number of papers</td><td>67</td><td>98</td><td>115</td><td>151</td></tr><tr><td>No statistical procedures</td><td>66%</td><td>59%</td><td>45%</td><td>30%</td></tr><tr><td>Statistical procedures other than t, χ² and r</td><td>3%</td><td>5%</td><td>12%</td><td>35%</td></tr></table>  

几位作者对期刊进行了全面研究，以了解哪些方法使用最频繁。表16.3显示了1978-79年《新英格兰医学杂志》综述中发现的方法，按使用频率递减排序，并列出了仅包含表中列出的方法的论文占所有论文的累积百分比。我们可以看到，列出的广泛技术涵盖了大多数但并非所有已发表的论文。过去十年中，更高级统计技术的使用进一步增加，因此使用表16.3中未显示方法的论文比例可能有所增加。  
Several authors have carried out a comprehensive study of journals to see which methods are in most frequent use. Table 16.3 shows the methods found in the review of the New England Journal of Medicine in 1978- 79 in decreasing order of use, with the cumulative percentage of all papers that contained only methods that far down the table. We can see that the wide range of techniques listed covers most but not all published papers. The last ten years have seen a further increase in the use of more advanced statistical techniques, so that the proportion of papers which use methods not shown in Table 16.3 is likely to have increased.  

表 16.2 1967-68 年和 1982 年《关节炎与风湿病》杂志中选定统计方法的使用情况及发现的错误数量 (Felson 等人，1984)  
Table 16.2 Use of selected statistical methods in Arthritis and Rheumatism in 1967-68 and 1982, and numbers of errors found (Felson et al., 1984)  

<table><tr><td></td><td>1967-68  
<table><tr><td></td><td>1967-68  
(n = 47)</td><td>1982  
(n = 47)</td><td>1982  
(n = 74)</td></tr><tr><td>统计方法：</td><td></td><td></td></tr><tr><td>t 检验</td><td>8 (17%)</td><td>37 (50%)</td></tr><tr><td>卡方检验</td><td>9 (19%)</td><td>22 (30%)</td></tr><tr><td>线性回归</td><td>1 (2%)</td><td>18 (24%)</td></tr><tr><td>多重统计检验</td><td>4 (9%)</td><td>30 (41%)</td></tr><tr><td>错误：</td><td></td><td></td></tr><tr><td>未定义方法</td><td>14 (30%)</td><td>7 (9%)</td></tr><tr><td>位置或离散度测量描述不足</td><td>6 (13%)</td><td>7 (9%)</td></tr><tr><td>重复观测被视为独立观测</td><td>1 (2%)</td><td>4 (5%)</td></tr><tr><td>两组在 5% 水平上比较 &amp;gt; 10 3 (6%) 个变量</td><td>28 (38%)</td><td></td></tr><tr><td>使用多重 t 检验而非方差分析</td><td>2 (4%)</td><td>18 (24%)</td></tr><tr><td>期望频率过小时使用卡方检验</td><td>3 (6%)</td><td>4 (5%)</td></tr><tr><td>至少存在上述一项错误</td><td>28 (60%)</td><td>49 (66%)</td></tr></table>  
(n = 74)</td></tr><tr><td>Statistical method:</td><td></td><td></td></tr><tr><td>t test</td><td>8 (17%)</td><td>37 (50%)</td></tr><tr><td>Chi squared test</td><td>9 (19%)</td><td>22 (30%)</td></tr><tr><td>Linear regression</td><td>1 (2%)</td><td>18 (24%)</td></tr><tr><td>Multiple statistical tests</td><td>4 (9%)</td><td>30 (41%)</td></tr><tr><td>Error:</td><td></td><td></td></tr><tr><td>Undefined method</td><td>14 (30%)</td><td>7 (9%)</td></tr><tr><td>Inadequate description of measures of location or dispersion</td><td>6 (13%)</td><td>7 (9%)</td></tr><tr><td>Repeated observations treated as independent</td><td>1 (2%)</td><td>4 (5%)</td></tr><tr><td>Two groups compared on &amp;gt; 10 3 (6%) variables at 5% level</td><td>28 (38%)</td><td></td></tr><tr><td>Multiple t tests instead of analysis of variance</td><td>2 (4%)</td><td>18 (24%)</td></tr><tr><td>Chi squared tests used when expected frequencies too small</td><td>3 (6%)</td><td>4 (5%)</td></tr><tr><td>At least one of above errors</td><td>28 (60%)</td><td>49 (66%)</td></tr></table>  

因此，医学文献中的统计方法学存在巨大的多样性。不幸的是，如下一节所示，已发表论文中统计信息的可靠性令人担忧地低。因此，能够批判性地评估研究论文至关重要，为此，需要熟悉大量的统计概念和方法。除了流行病学方法，表 16.3 中列出的所有主题都包含在本书中。  
There is thus an enormous diversity of statistical methodology in the medical literature. Unfortunately, as shown in the next section, the reliability of the statistical information in published papers is worryingly low. Thus it is essential to be able to assess critically research papers, to which end it is necessary to be familiar with a large range of statistical concepts and methods. Apart from epidemiological methods, all of the topics listed in Table 16.3 are included in this book.  

除了统计分析方法的变化之外，研究设计类型也同时发生了变化。对《新英格兰医学杂志》在类似时期（1946-76 年）发表的研究设计进行回顾，结果显示临床试验的数量和对照试验的比例有所增加，但队列研究有所减少，转而倾向于横断面研究 (Fletcher 和 Fletcher, 1979)。关于临床试验的著述很多，但它们在医学期刊发表的所有论文中仍然只占极少数，可能仅为 $5\%$。  
As well as changes in the methods of statistical analysis there has been a simultaneous change in the types of research design used. A review of the design of studies published in the New England Journal of Medicine over a similar period (1946- 76) showed an increase in clinical trials, and in the proportion of trials that were controlled, but also a decrease in cohort studies in favour of cross- sectional studies (Fletcher and Fletcher, 1979). Much is written about clinical trials, but they still represent a small minority, perhaps only  $5\%$ , of all papers published in medical journals.  

表 16.3 1978-79 年《新英格兰医学杂志》中最常见的统计技术 (Emerson 和 Colditz, 1983)  
Table 16.3 The most common statistical techniques in the New England Journal of Medicine in 1978-79 (Emerson and Colditz, 1983)  

<table><tr><td>技术</td><td>论文累计百分比</td></tr><tr><td>1 无统计方法或仅描述性方法</td><td>58</td></tr><tr><td>2 t 检验</td><td>67</td></tr><tr><td>3 列联表 (x²)</td><td>73</td></tr><tr><td>4 非参数检验</td><td>75</td></tr><tr><td>5 流行病学方法</td><td>77</td></tr><tr><td>6 皮尔逊相关 (r)</td><td>79</td></tr><tr><td>7 简单线性回归</td><td>82</td></tr><tr><td>8 方差分析</td><td>84</td></tr><tr><td>9 变换</td><td>86</td></tr><tr><td>10 秩相关</td><td>87</td></tr><tr><td>11 生命表分析</td><td>89</td></tr><tr><td>12 多元回归</td><td>90</td></tr><tr><td>13 多重比较</td><td>92</td></tr></table>  
<table><tr><td>Technique</td><td>Cumulative % of papers</td></tr><tr><td>1 No statistical methods or descriptive methods only</td><td>58</td></tr><tr><td>2 t tests</td><td>67</td></tr><tr><td>3 Contingency tables (x²)</td><td>73</td></tr><tr><td>4 Non-parametric tests</td><td>75</td></tr><tr><td>5 Epidemiological methods</td><td>77</td></tr><tr><td>6 Pearson correlation (r)</td><td>79</td></tr><tr><td>7 Simple linear regression</td><td>82</td></tr><tr><td>8 Analysis of variance</td><td>84</td></tr><tr><td>9 Transformations</td><td>86</td></tr><tr><td>10 Rank correlation</td><td>87</td></tr><tr><td>11 Life table analysis</td><td>89</td></tr><tr><td>12 Multiple regression</td><td>90</td></tr><tr><td>13 Multiple comparisons</td><td>92</td></tr></table>  

## 16.3 已发表论文中的统计学  16.3 STATISTICS IN PUBLISHED PAPERS  

显然，统计方法的滥用从一开始就是一个问题。早在 1932 年，格林伍德在评论过去 20 年的变化时写道：‘医学论文现在经常包含统计分析，有时这些分析是正确的，但作者违反统计学或一般逻辑推理基本原则的频率与以前一样高’ (Greenwood, 1932)。1950 年，霍格本写道：‘不到 1% 的研究人员清楚地理解他们常用统计技术的原理’ (Hogben, 1950)。最近的一条评论也传达了同样的信息：‘阅读任何一期主要的癌症期刊，几乎不可能不引发对研究设计、数据收集、反应定义、结果确定和结果报告的严重质疑’ (Hoogstraten, 1984)。这些评估没有得到已发表论文内容的系统性回顾的支持，但自 20 世纪 60 年代以来，已经有许多此类回顾。  
It is clear that the misuse of statistical methods has been a problem from the outset. As early as 1932, commenting on changes over the preceding 20 years, Greenwood wrote: 'Medical papers now frequently contain statistical analyses, and sometimes these analyses are correct, but the writers violate quite as often as before, the fundamental principles of statistical or of general logical reasoning' (Greenwood, 1932). In 1950 Hogben wrote 'Less than 1 per cent of research workers clearly apprehend the rationale of statistical techniques they commonly invoke' (Hogben, 1950). A much more recent comment contains the same message: 'It is nearly impossible to read an issue of leading cancer journals without giving rise to serious questions about study design, data collection, definitions of response, determination of results, and the reporting of results' (Hoogstraten, 1984). These assessments were not supported by systematic reviews of the content of published papers, but since the 1960s there have been many such reviews.  

### 16.3.1 文献综述  16.3.1 Reviews of the literature  

我所知的最早关于医学期刊统计质量的评论是 Dunn (1929) 的，他观察到所审查的一系列已发表论文中有一半在统计上不可接受。最早的现代综述之一是 Schor 和 Karten (1966) 对十本医学期刊中发表的 295 篇论文进行的审查。他们认为 $28\%$ 的论文在统计上可接受，$68\%$ 有缺陷，而 $5\%$ 则“无法挽救”。随后对众多不同综合性及专业期刊发表论文的许多综述都发现了大致相似的情况。由于评论者使用的标准范围广泛，因此很难对这些研究进行总结，但它们通常发现，所审查的论文中约有一半至少包含一个统计错误。这些错误的重要性也难以界定。当然，许多小错误对研究的总体结论没有实质性影响，但有些可能导致重大的解释错误。  
The earliest comment I know of relating to the quality of statistics in medical journals is that by Dunn (1929), who observed that half of a series  

大多数评论者关注统计分析中的错误，但也有一些关注设计中的错误，特别是临床试验。例如，Tyson 等人 (1983) 使用预设标准，审查了发表在四本期刊上的 86 份围产期医学治疗性试验报告。他们的结果总结在表 16.4 中，显示所审查论文存在重大缺陷。一些缺失的信息可能归因于报告不佳而非设计缺陷，但阅读论文时，我们不能假设未说明的事项。例如，如果一份临床试验报告提到使用了随机分配但未提供进一步信息  
of published papers examined were not acceptable statistically. One of the first modern reviews was by Schor and Karten (1966) who examined 295 papers published in ten medical journals. They considered that  $28\%$  of the papers were statistically acceptable,  $68\%$  were deficient, and  $5\%$  were 'unsalvageable'. The many subsequent reviews of papers published in numerous different general and specialist journals have found a broadly similar picture. It is difficult to summarize these studies because of the wide range of criteria used by the reviewers, but they have typically found that about half of the papers examined included at least one statistical error. It is also hard to say how important these errors are. Certainly many minor errors will have no material bearing on the overall conclusions of a study, but some may lead to major errors of interpretation.  

大多数评论者关注统计分析中的错误，但也有一些关注设计中的错误，特别是临床试验。例如，Tyson 等人 (1983) 使用预设标准，审查了发表在四本期刊上的 86 份围产期医学治疗性试验报告。他们的结果总结在表 16.4 中，显示所审查论文存在重大缺陷。一些缺失的信息可能归因于报告不佳而非设计缺陷，但阅读论文时，我们不能假设未说明的事项。例如，如果一份临床试验报告提到使用了随机分配但未提供进一步信息  
Most reviewers have looked at errors in statistical analysis, but some have looked at errors in design, especially for clinical trials. For example, Tyson et al. (1983) reviewed reports of 86 therapeutic trials in perinatal medicine published in four journals, using predetermined criteria. Their results are summarized in Table 16.4, and show major deficiencies in the papers examined. Some of the missing information may be due to poor reporting rather than bad design, but when reading a paper we cannot assume things that are not stated. For example, if a report of a clinical trial mentions that random allocation was used but offers no further information  

表 16.4 围产期医学 86 项治疗性试验综述总结 (Tyson 等人，1983)  
Table 16.4 Summary of review of 86 therapeutic trials in perinatal medicine (Tyson et al.,1983)  

<table><tr><td rowspan="2"></td><td colspan="3">% 符合标准的研究所占比例</td></tr><tr><td>是</td><td>不明确</td><td>否</td></tr><tr><td>目的陈述</td><td>94</td><td>6</td><td>0</td></tr><tr><td>明确定义结局变量</td><td>74</td><td>1</td><td>25</td></tr><tr><td>计划的前瞻性数据收集</td><td>48</td><td>30</td><td>22</td></tr><tr><td>预先确定的样本量（或序贯试验）</td><td>3</td><td>16</td><td>71</td></tr><tr><td>指定样本量</td><td>93</td><td>6</td><td>1</td></tr><tr><td>受试者疾病/健康状况指定（n = 85）</td><td>51</td><td>20</td><td>29</td></tr><tr><td>指定排除标准（n = 81）</td><td>46</td><td>9</td><td>45</td></tr><tr><td>随机化（如果可行）适当执行并记录（n = 69）</td><td>9</td><td>12</td><td>79</td></tr><tr><td>使用盲法，或非盲法不太可能导致结果偏倚（n = 83）</td><td>49</td><td>47</td><td>4</td></tr><tr><td>足够的样本量</td><td>15</td><td>44</td><td>41</td></tr><tr><td>统计方法已识别、适当使用和解释</td><td>26</td><td>0</td><td>74</td></tr><tr><td>建议/结论合理</td><td>10</td><td>71</td><td>19</td></tr></table>  
<table><tr><td rowspan="2"></td><td colspan="3">% of studies fulfilling criteria</td></tr><tr><td>Yes</td><td>Unclear</td><td>No</td></tr><tr><td>Statement of purpose</td><td>94</td><td>6</td><td>0</td></tr><tr><td>Clearly defined outcome variables</td><td>74</td><td>1</td><td>25</td></tr><tr><td>Planned prospective data collection</td><td>48</td><td>30</td><td>22</td></tr><tr><td>Predetermined sample size (or a sequential trial)</td><td>3</td><td>16</td><td>71</td></tr><tr><td>Sample size specified</td><td>93</td><td>6</td><td>1</td></tr><tr><td>Disease/health status of subjects specified (n = 85)</td><td>51</td><td>20</td><td>29</td></tr><tr><td>Exclusion criteria specified (n = 81)</td><td>46</td><td>9</td><td>45</td></tr><tr><td>Randomization (if feasible) appropriately performed and documented (n = 69)</td><td>9</td><td>12</td><td>79</td></tr><tr><td>Blinding used, or lack of blinding unlikely to have biased results (n = 83)</td><td>49</td><td>47</td><td>4</td></tr><tr><td>Adequate sample size</td><td>15</td><td>44</td><td>41</td></tr><tr><td>Statistical methods identified, appropriately used and interpreted</td><td>26</td><td>0</td><td>74</td></tr><tr><td>Recommendations/conclusions justified</td><td>10</td><td>71</td><td>19</td></tr></table>  

关于所用程序的说明，我们不能假定他们确实进行了随机化。许多研究人员不理解“随机”的含义。同样，当统计方法未被明确指出时（这种情况经常发生），我们不能假定这些方法是恰当的。这就是为什么评论者在近四分之三的受审论文中，都无法判断其结论是否合理。  
about the procedure used, we cannot assume that they really did randomize. Many researchers do not understand what 'random' means. Likewise, we cannot assume that the statistical methods were appropriate when, as is often the case, the methods are not identified. This is why the reviewers felt unable to judge whether the conclusions were justified in nearly three- quarters of the papers examined.  

最近对大约 150 项此类研究进行了一项全面的综述（Johnson 和 Altman, 1990; Altman 和 Johnson, 1990）。该综述提供的证据表明，错误发生的频率并未随时间减少，尽管更近期的评论者可能对他们所认为的错误采取了更严格的态度。  
A comprehensive review of about 150 such studies has been carried out recently (Johnson and Altman, 1990; Altman and Johnson, 1990). It provides little evidence that the frequency of errors is diminishing over time, although it is likely that more recent reviewers have taken a harder line over what they considered to be errors.  

统计错误可能发生在研究的任何阶段：计划、设计、执行、分析、呈现和解释。在计划研究时，如果对其他已发表论文的结果不加批判地接受，可能会对设计或样本量做出不正确的判断。然而，从设计到解释的其他研究阶段，是更容易出错的地方，我将逐一探讨。所给出的例子绝非全面。  
Statistical errors can occur at any stage of a study: planning, design, execution, analysis, presentation and interpretation. When planning a study, it is possible to make incorrect judgements about the design or sample size if the findings of other published papers are accepted uncritically. However, the other stages of research, from design through to interpretation, are more obvious places where things can go wrong, and I shall consider each in turn. The examples given are by no means comprehensive.  

### 16.3.2 设计中的错误  16.3.2 Errors in design  

对临床试验的综述显示，在报告与试验设计和执行相关的关键信息方面存在重大缺陷。或许更令人担忧的是，这些综述还表明，相当一部分论文报告的研究采用了次优设计。例如，尽管有大量文献敦促临床试验采用尽可能高的设计标准，但研究仍然普遍在没有同期对照组，或有同期但非随机对照组的情况下进行，并且在可以采用盲法时却未使用。一个主要担忧是，设计较差的研究容易产生偏倚，特别是可能得出过于乐观的结果。Fletcher 和 Fletcher（1979）给出了几个例子，其中基于薄弱研究设计得出的结论后来被后续设计良好的研究纠正。所有比较设计良好和设计不佳的相同治疗临床试验结果的综述都发现，后者获得了更大的治疗效果（Altman 和 Johnson，1990）。如果像可能的那样，较弱的研究也较小，那么发表偏倚（参见第 15.5.2 节）的影响可能更严重。  
Reviews of clinical trials have shown major deficiencies in the reporting of vital information relating to the design and execution of the trial. Perhaps more worryingly, they have also shown that a fair proportion of papers report studies that have used suboptimal design. For example, despite a huge literature urging the highest possible standards of design for clinical trials, studies are still commonly carried out without concurrent controls, or with concurrent but non- randomized controls, and blinding is not used when it could have been. A major worry is that studies with inferior designs are open to bias, and in particular may produce over- optimistic findings. Fletcher and Fletcher (1979) give several examples where conclusions based on weak research designs were later corrected by subsequent well designed studies. All reviews comparing the results of well designed and poorly designed clinical trials of the same treatments have found that the latter obtained larger treatment effects (Altman and Johnson, 1990). If, as is likely, the weaker studies are also smaller, then the effect of publication bias (see section 15.5.2) may be more severe.  

这些问题不限于临床试验。对评估诊断性试验的研究综述同样显示，在设计和报告方面存在重大缺陷（Sheps 和 Schechter，1984）。然而，在临床试验领域之外，很难对主要错误做出一般性陈述；第 5 章给出了几个潜在困难的例子。  
The problems are not confined to clinical trials. Reviews of studies evaluating diagnostic tests have similarly been shown to have major deficiencies in design and reporting (Sheps and Schechter, 1984). However, outside the field of clinical trials it is harder to make general statements about the main errors that are made; Chapter 5 gave several examples of potential difficulties.  

导致某些问题的一个原因是，许多研究实际上并非“设计”出来的，而是“碰巧发生”的。它们基于对为其他目的收集的现有数据的分析。虽然许多此类研究报告承认研究是回顾性的，但有些却假装研究是前瞻性的，因此是经过计划的，因为暗示想法先于数据会显得更好。未设计研究的症状包括所用治疗和评估方法的变化、不同受试者的观察次数不均、许多缺失观察值，以及对所做工作和原因的普遍模糊性。  
One reason for some of the problems is that many studies are not actually designed but rather 'happen'. They are based on an analysis of pre- existing data that were collected for some other purpose. While many reports of such studies admit that the study was retrospective, some pretend that the study was prospective, and thus planned, as it looks better to suggest that the idea came before the data. Symptoms of undesigned studies are variation in the treatments and methods of evaluation used, unequal numbers of observations for different subjects, many missing observations, and a general vagueness about what was done and why.  

使用现有数据的一个例子体现在许多使用胎儿超声测量来建立参考标准的研究中。几乎所有已发表的研究都基于对现有数据的分析，因此每个胎儿的观察次数不同，并且测量不是在预先指定的时间进行的。虽然早期妊娠的单次常规超声检查很常见，但除非有临床担忧，否则进一步的超声测量并不常见。因此，在这些数据集中多次出现的胎儿可能是不典型的，并且平均大小很可能不同，从而导致数据与它们声称的并不相符。Green 和 Byar（1984）讨论了分析来自注册表而非为手头目的收集的数据可能产生的一些问题。  
An example of the use of existing data is seen in many studies using fetal ultrasound measurements to develop reference standards. Virtually all published studies are based on the analysis of existing data, so that the number of observations per fetus varies and the measurements are not taken at pre- specified times. While a single routine ultrasound examination in early pregnancy is common, further ultrasound measurements are not usual unless there is some cause for clinical concern. Thus those fetuses that are represented several times in these data sets are likely to be atypical and quite possibly of a different size on average, so that the data are not what they purport to be. Green and Byar (1984) have discussed some of the problems that can arise from the analysis of data from registries rather than data collected for the purpose in hand.  

其他设计问题在第 5 章中有所提及。例如，选择不适当的高危样本来推断一般人群；病例对照研究中选择不适当的对照组；以及当人们可以选择治疗时产生的志愿者偏倚。另一个潜在问题的例子是“健康工人效应”，即就业人员比一般人群更健康；在研究工业暴露于某种危害可能产生的不利影响时需要考虑这一点。还有一个是在研究中采用不同观察者来比较两种替代测量方法（参见第 14.2 节）。如果每种方法只由一名观察者使用，那么观察者之间任何系统性差异与方法之间任何差异是不可分离的（或称“混淆”）。  
Other design problems were referred to in Chapter 5. Examples are the choice of an inappropriate high risk sample to make inferences about the general population; choice of inappropriate controls in a case- control study; and the volunteer bias that arises when people can choose their treatment. Another example of a potential problem is the 'healthy worker effect', whereby people in employment are healthier than the general population; this needs to be considered in studies of possible adverse effects of industrial exposure to some hazard. Yet another is the use of different observers in a study to compare two alternative methods of measurement (see section 14.2). If each method is used by only one observer there is an inseparability (or 'confounding') of any systematic differences between the observers with any difference between the methods.  

这些少数例子仅用于说明各种可能的陷阱。冒着重复的风险，我将再次强调，寻求专家统计建议的最佳时机是在您计划研究时，以便能够发现并纠正此类缺陷。  
These few examples serve only to illustrate the wide variety of possible pitfalls. At the risk of repetition, I shall say again that the best time to seek expert statistical advice is when you are planning a study, so that any flaws of this sort can be spotted and rectified.  

最后，存在样本量不足这个根本问题。正如第 8.5.4 节所指出的，Freiman 等人（1978）的一项综述显示，许多已发表的临床试验发现治疗之间没有显著差异，但由于样本量小，几乎没有机会检测到主要的治疗效果。很少有已发表的研究报告样本量是根据功效计算选择的。事实上，  
Lastly, there is the fundamental problem of having an inadequate sample size. As noted in section 8.5.4, a review by Freiman et al. (1978) showed that many published clinical trials that find a non- significant difference between treatments had little chance of detecting major treatment effects due to small sample sizes. Few published studies report that the sample size was chosen on the basis of power calculations. Indeed, the concept of  

样本量计算的概念在临床试验领域之外的医学研究中似乎几乎不为人知，尽管相同的方法同样适用于所有比较研究，并且可用于规划任何调查。例如，最近一篇论文讨论了流变学研究的样本量计算（Stuart 等人，1989）。  
sample size calculations seems almost unknown in medical research outside the field of clinical trials, although the same methods are equally applicable to all comparative studies and can be used in planning any investigation. For example, a recent paper has discussed sample size calculations for rheological studies (Stuart et al., 1989).  

即使已经使用功效计算来确定样本量，受试者的供应也可能不如预期。在临床试验中，实际招募率远低于预期是很常见的，部分原因是高估了符合条件的受试者数量，部分原因是他们不愿参加试验。  
Even when power calculations have been used to calculate sample size, the supply of subjects may not be as great as anticipated. It is common in clinical trials for the actual recruitment rate to fall far short of that anticipated, partly because of overestimation of the number of eligible subjects and partly because of their unwillingness to enter the trial.  

虽然 $\mathbf{P}$ 值可以掩盖研究规模过小的事实，但非常宽的置信区间表明缺乏有用的信息—这是支持使用置信区间论点之一（参见第 8.8 节）。  
Whereas  $\mathbf{P}$  values can disguise the fact that a study was too small, a very wide confidence interval indicates the lack of useful information - this is one of the arguments in favour of the use of confidence intervals (see section 8.8).  

### 16.3.3 执行中的错误  16.3.3 Errors in execution  

尤其是在前瞻性研究中，数据收集可能不会按计划进行。另一种表达方式是，研究计划或方案没有严格遵守。第15章讨论了临床试验中可能出现的各种问题，特别是关于正确排除不符合条件的受试者以及确保每位患者接受到分配给他们的治疗。人们可能认为，简单的分配方案，例如基于奇数或偶数的方案，更不容易出错，但事实并非如此。在一项使用手术日期的奇偶性和出生年份的奇偶性将受试者分配到三种不同类型心脏瓣膜假体的研究报告中，作者写道：“我们发现……随机化程序在整个研究期间并非完全一致，部分原因是供应困难，部分原因是奇偶标准有时被误解了”（Kuntze 等，1989）。没有给出更多细节。提及供应困难表明可能有时并非所有三种设备都可用，但我们没有被告知如何处理这种情况。奇偶日期的问题表明，这种看似简单的方案实际上可能比例如使用预制信封的随机化更难正确操作，此外，从其他原因来看，这也是一种劣质设计。（当然，他们使用的分配系统并非随机化，正如他们错误声称的那样。）  
In prospective studies in particular, the collection of data may not go according to plan. Another way of expressing this idea is that the study plan or protocol is not strictly adhered to. Various problems that can occur in clinical trials were discussed in Chapter 15, notably with regard to the correct exclusion of ineligible subjects and ensuring that each patient received the treatment that was allocated to them. It might be thought that simple allocation schemes, such as those based on odd or even numbers, would be less prone to error, but this is not so. In the report of a study that used both odd and even date of operation and odd or even year of birth to allocate subjects to three different types of heart valve prothesis, the authors wrote: 'We found … that the randomisation procedure was not entirely consistent throughout the study period, partly because of supply difficulties and partly because the odd/even criteria were sometimes misunderstood' (Kuntze et al., 1989). No further details were given. The mention of supply difficulties suggests that there may have been times when not all three devices were available, but we are not told how this was dealt with. The problems with odd and even dates suggest that this apparently simple scheme may indeed be harder to operate correctly than, for example, randomization using prepared envelopes, apart from this being an inferior design for other reasons. (Of course, the allocation system they used was not randomization, as they wrongly claimed.)  

数据缺失可能是数据收集系统故障的结果，例如，由于忽视考虑周末或节假日期间会发生什么。如果数据直到研究结束才被检查，那么当发现任何问题时，纠正它们就已经太晚了。  
Missing data may be the consequence of a failure in the data collection system, for example arising from neglecting to consider what would happen during weekends or holidays. If the data are not examined until the end of the study, by the time that any problems are spotted it will be too late to rectify them.  

### 16.3.4 分析中的错误  16.3.4 Errors in analysis  

分析中的错误令人遗憾地普遍存在。在本书前面的章节中，我曾警告过不要不当地使用所介绍的方法。这些警告是基于对医学期刊中此类误用普遍存在的了解。因此，以下基本错误经常发生：  
Errors in analysis are regrettably common. In earlier chapters of this book I have warned against improper uses of the methods introduced. These warnings are based on knowledge that such misuses are common in medical journals. Thus the following basic errors are frequently made:  

1. 在不满足假设条件时使用分析方法；   
1. using methods of analysis when the assumptions are not met;   
2. 分析配对数据时忽略配对；   
2. analysing paired data ignoring the pairing;   
3. 未能考虑有序分类；   
3. failing to take account of ordered categories;   
4. 将一个受试者的多次观察视为独立；   
4. treating multiple observations on one subject as independent;   
5. 使用多重配对比较而非考虑所有组的分析（例如方差分析）；   
5. using multiple paired comparisons instead of an analysis that considers all groups (e.g. analysis of variance);   
6. 进行组内分析，然后通过比较 $\mathbf{P}$ 值或置信区间来比较组间差异；   
6. performing within group analyses and then comparing groups by comparing  $\mathbf{P}$  values or confidence intervals;   
7. 引用包含不可能值的置信区间。  
7. quoting confidence intervals that include impossible values.  

我将这些错误描述为“基本”错误，因为它们表明对基本统计概念缺乏理解。它们确实是不可原谅的。  
I have described these errors as 'basic' because they demonstrate a lack of understanding of fundamental statistical concepts. They are not really excusable.  

然而，还有其他错误，它们可能同样甚至更严重，但这些错误更多是逻辑上的而非技术上的。一些例子（均在前面章节中讨论过）包括：  
There are other errors, however, which may be equally or even more serious but where the error is more one of logic than technique. Some examples, all discussed in earlier chapters, are:  

1. 在方法学比较研究中使用相关性；   
1. using correlation in method comparison studies;   
2. 使用相关性比较两组与时间相关的观测值；   
2. using correlation to compare two sets of time-related observations;   
3. 通过假设检验评估两个或多个组的可比性；   
3. assessing the comparability of two or more groups by means of hypothesis tests;   
4. 仅通过敏感性和特异性评估诊断试验。  
4. evaluating a diagnostic test solely by means of sensitivity and specificity.  

这些错误可能更容易被原谅，因为它们更为微妙，尽管这些错误在医学期刊中已被多次论述。但期刊在论文提交时未能发现这些错误，这几乎是不可原谅的。  
There is perhaps rather more excuse for these errors being made as they are rather more subtle, although the errors have been written about many times in medical journals. There is little excuse for journals not detecting them when papers are submitted.  

另一种不可接受的做法是基于数据的子集得出结论。除了对许多子集或亚组进行研究会导致出现某种结果（即得出 $\mathbf{P}< 0.05)$ 的高概率之外，将子集分析作为主要发现呈现可能会扭曲整体情况。一个例子是比较两种乳腺癌患者化疗方案的临床试验（Lippman et al., 1984）。两组疾病进展时间的总体比较通过对数秩检验进行，结果为 $\mathbf{P} = 0.26$ 。然而，作者也仅比较了对治疗有反应的患者的疾病进展时间，结果显示组间存在显著差异 $(\mathbf{P} = 0.009)$ 。论文摘要中只出现了后者的分析，没有提及总体上没有显著差异。要么是治疗反应的比例，要么  
Another unacceptable practice is to base conclusions on a subset of the data. Apart from the fact that investigation of many subsets or subgroups will lead to a high probability that something will turn up (i.e. yield  $\mathbf{P}< 0.05)$  , presentation of a subset analysis as the main finding may distort the picture. An example is given in a clinical trial comparing two chemotherapy regimes in breast cancer patients (Lippman et al., 1984). The overall comparison of time to progression of disease in the two groups was performed by the logrank test and gave  $\mathbf{P} = 0.26$  . However, the authors also compared the time to progression among only those patients who responded to treatment, for whom there was a significant difference between the groups  $(\mathbf{P} = 0.009)$  . Only the latter analysis appears in the summary of the paper, with no mention that there was no overall significant difference. Either the proportion responding to treatment or  

疾病进展时间（或生存时间）可能被认为是这项研究的合适终点，但比较必须基于所有患者，而不是选定的子集。  
time to progression (or survival time) might be considered a suitable end- point for this study, but the comparison must be based on all patients, not a selected subset.  

### 16.3.5 报告中的错误  16.3.5 Errors in presentation  

在结果的报告中，医学期刊中也存在一些常见的错误：  
With presentation of results too there are several common errors that abound in medical journals:  

1. 将标准误（或置信区间）用于描述性信息；   
1. using standard errors (or confidence intervals) for descriptive information;   
2. 呈现连续数据的均值（或中位数）而没有给出任何变异性指标；   
2. presenting means (or medians) of continuous data without any indication of variability;   
3. 仅以 $\mathbf{P}$ 值呈现统计分析结果。  
3. presenting the results of a statistical analysis solely as a  $\mathbf{P}$  value.  

除了最后一个问题，所有这些问题都同样适用于数值和图形报告。  
All but the last of these problems relate equally to numerical and graphical presentation.  

#### (a) 数值精度  (a) Numerical precision  

报告中一个常见的问题是用于呈现数据和结果的数值精度不足。虚假的精度对论文毫无益处，反而会损害其可读性和可信度。虽然很难提供绝对的规则，但以下指南可能会有所帮助。在呈现汇总统计量或分析结果（如均值、标准差和回归方程）时，应考虑原始数据的精度。均值通常不应比原始数据多一位小数，但标准误和标准差可能需要多一位小数。百分比最多不需要超过一位小数，尤其是在小样本中。如果给出了分子和分母（通常应该如此），那么就没有理由不将百分比四舍五入到最接近的整数。检验统计量，如 $t$ 和 $X^{2}$，不需要超过两位小数。同样，$\mathbf{P}$ 值不需要超过一到两位有效数字，并且没有必要具体到低于，比如说，0.0001（参见第8.10节）。其他具体建议在前面的几章中已经给出。  
One aspect of presentation that is often poor is the numerical precision used to present data and results. Spurious precision adds nothing to a paper and impairs its readability and credibility. It is hard to provide absolute rules, but the following guidelines may help. When presenting summary statistics or the results of analyses, such as means, standard deviations and regression equations, the precision of the original data should be borne in mind. Means should not usually be quoted to more than one further decimal place than the raw data, but standard errors and standard deviations may require one extra decimal place. Percentages do not need to be given to more than one decimal place at most, especially in small samples. If the numerator and denominator are given, as should usually be the case, then there is no reason not to quote percentages to the nearest integer. Test statistics such as  $t$  and  $X^{2}$  do not need to be given to more than two decimal places. Likewise  $\mathbf{P}$  values do not need more than one or two significant digits, and it is not necessary to be specific below, say, 0.0001 (see section 8.10). Other specific advice is given in several earlier chapters.  

以下是一些不必要的（或虚假的）精度的例子，均来自已发表的论文：  
Some examples of unnecessary (or spurious) precision, all from published papers, are:  

$$
\begin{array}{r l}{P}&{=10^{-54}}\\ {P}&{=0.5254}\\ {r}&{=0.99299}\\ {\chi^{2}}&{=0.7264}\\ {\mathrm{~}^{86.95\%}\mathrm{~of~cases}^{\prime}}\end{array}
$$  

回归分析的一个例子是以下方程，它描述了  
An example from a regression analysis is the following equation relating  

出生体重（kg，BWt）与胸围（cm，CC）和中臂围（cm，AC）之间的关系（Bhargava 等，1985）  
birth weight in kg (BWt) to chest circumference (CC) and mid- arm circumference (AC) (both in cm) (Bhargava et al., 1985)  

$$
\mathbf{BWt} = - 3.0983527 + 0.142088\mathbf{CC} + 0.158039\mathbf{AC}
$$  

该方程声称能将出生体重预测到最接近的 $\frac{1}{10000} \mathrm{~g}！$ 许多此类例子可能源于计算机输出的精确转录。  
which purports to predict birthweight to the nearest  $\frac{1}{10000} \mathrm{~g}!$  Many such examples may arise from exact transcription from computer output.  

最后，在许多文献综述中发现的一个常见问题是，在均值后使用 $\pm$ 符号，但未指明该符号后的数字是标准差还是标准误。 $\pm$ 的用法已经存在了几十年，但其歧义性非常严重，以至于包括《英国医学杂志》和《柳叶刀》在内的几家医学期刊现在不允许使用它，尽管大多数期刊仍然允许。因此，例如，“平均血压为 $92.4 \pm 7.1 \mathrm{~mm} \mathrm{Hg}$ ”这样的表述将改为“平均血压为 $92.4 \mathrm{~mm} \mathrm{Hg}$ (SD 7.1)”（如果是标准误，则为SE）。这种首选的符号表示法是明确的，并且避免了标准差（或标准误）可以是正或负，以及均值 $\pm \mathrm{SD}$ （或均值 $\pm \mathrm{SE}$ ）所给出的范围具有特殊意义的错误暗示。  
Lastly, a common problem found in many reviews of the literature is the use of the  $\pm$  sign after a mean without specifying whether the number after the sign is the standard deviation or standard error. The  $\pm$  usage has been around for many decades, but the ambiguity is so serious that several medical journals, including the British Medical Journal and Lancet, do not now allow its use, although most journals still do. Thus, for example, the phrase 'the mean blood pressure was  $92.4 \pm 7.1 \mathrm{~mm} \mathrm{Hg}$ ' would be changed to 'the mean blood pressure was  $92.4 \mathrm{~mm} \mathrm{Hg}$  (SD 7.1)' (or SE if that were the case). The preferred notation is unambiguous and also avoids the incorrect implications that the standard deviation (or standard error) can be positive or negative and that the range given by mean  $\pm \mathrm{SD}$  (or mean  $\pm \mathrm{SE}$ ) is of especial interest.  

#### (b) 图形展示  (b) Graphical presentation  

尽管有些结果只能以表格形式或图形形式显示，但在两者皆可的情况下，哪种方式更优存在很大不确定性（期刊不允许作者以两种方式展示相同的数据）。同样，我认为不可能给出简单的通用指导。表格能更准确地呈现结果，但许多人认为图表更利于理解数据的核心信息。图表在显示个体受试者数据时（例如散点图或时间趋势图）最具优势，而不是仅显示汇总信息。  
Although some results can be displayed only as a table or only as a graph, in cases where either is possible there is much uncertainty about which is preferable (journals will not allow the author to display the same data both ways). Again, I do not think it is possible to give simple general guidance. Results are given more accurately in tables, but many people find graphs preferable for seeing the message of the data. Graphs are most advantageous when they show data for individual subjects, for example as scatter diagrams or time trends, rather than summary information.  

本文没有篇幅全面讨论图形展示的注意事项。现在有几本专门讨论该主题的书籍，其中 Tufte (1983) 的著作尤其值得一读。然而，在本节的背景下，值得考虑图表可能产生误导的一些方式。  
There is not room here for a comprehensive discussion of the dos and don'ts of graphical presentation. There are now several books devoted to the topic, of which that by Tufte (1983) is particularly worth reading. In the context of this section, however, it is worth considering some ways in which graphs can be misleading.  

散点图是一种特别有价值的图表类型，它赋予相关或回归分析以意义。同样，显示多个受试者组内所有观测值的图表远优于仅显示汇总统计量的图表。图 3.14 和图 9.6 均以两种风格展示了同一组数据，从而说明了这种对比。仅显示汇总统计量（如均值和标准误）的图表（图 9.6）很少值得它们所占用的空间。  
Scatter diagrams are a particularly valuable type of graph, and give meaning to a correlation or regression analysis. Likewise graphs that show all observations within several groups of subjects are far preferable to those showing just summary statistics. The contrast is illustrated by Figures 3.14 and 9.6, which show the same set of data in both styles. Graphs showing only summary statistics, such as means and standard errors (Figure 9.6), are rarely worth the space they occupy.  

图表常见的误导性特征有：  
Common misleading features of graphs are:  

1. 纵轴缺乏真实的零点；   
1. the lack of a true zero on the vertical axis;   
2. 坐标轴中途改变刻度（在直方图中尤其恶劣）；3. 三维效果；4. 散点图中未能显示重合点；5. 在没有原始数据散点图的情况下显示拟合回归线；6. 叠加两个（或更多）具有不同纵轴刻度（尤其是当它们不从零开始时）的图表；7. 绘制均值而未显示任何变异性指标。  
2. a change of scale in the middle of an axis (especially heinous in a histogram); 3. three- dimensional effects; 4. failure to show coincident points in a scatter diagram; 5. showing a fitted regression line without a scatter diagram of the raw data; 6. superimposing two (or more) graphs with different vertical scales (especially when they do not start at zero); 7. plotting means without any indication of variability.  

最后一个问题很常见，然而，添加标准差或标准误不可避免地导致图表混乱。如前所述，这类数据放在表格中可能更好。对于序列数据，有更好的方法，如第14.6节所述。  
The last of these problems is common, and yet the addition of standard deviations or standard errors inevitably leads to a cluttered graph. As noted, this type of data may be better in a table. In the case of serial data, there are better approaches, as outlined in section 14.6.  

关于这些以及许多其他问题的进一步讨论，可在 Tufte (1983)、Cleveland (1984) 和 Wainer (1984) 的著作中找到。  
Further discussion of these and many other issues can be found in Tufte (1983), Cleveland (1984) and Wainer (1984).  

### 16.3.6 解释中的错误  16.3.6 Errors in interpretation  

对统计分析结果的解释中，大多数错误似乎都与假设检验和 $\mathbf{P}$ 值有关。其中许多要点已在前面的章节中讨论过，但在此值得重申的是，$\mathbf{P}$ 值并非像通常错误地宣称的那样，是观察到的效应由偶然性引起的概率，而是当原假设为真时，获得观察到的效应（或更不可能的效应）的概率。换句话说，$\mathbf{P}$ 评估的是，当总体中不存在这种差异时，在样本中观察到这种效应的可能性有多大。  
It seems that the majority of errors in the interpretation of statistical analyses relate to hypothesis tests and  $\mathbf{P}$  values. Many of these points have been covered in earlier chapters, but it is worth reiterating here that the  $\mathbf{P}$  value is not, as is commonly wrongly stated, the probability that the observed effect is due to chance, but rather the probability of obtaining the observed effect (or a more unlikely one) when the null hypothesis is true. In other words,  $\mathbf{P}$  assesses how likely it is to observe such an effect in a sample when there is no such difference in the population.  

另一种错误的解释是，认为 $\mathbf{P}$ 值为，比如说，0.001 意味着比 $\mathbf{P} = 0.01$ 更强的效应。虽然这可能如此，但 $\mathbf{P}$ 值本身并不能证明这一点。  
Another false interpretation is the belief that a  $\mathbf{P}$  value of, say, 0.001 implies a stronger effect than  $\mathbf{P} = 0.01$ . While this may be so, the  $\mathbf{P}$  values do not demonstrate it.  

对“显著”和“不显著”的 $\mathbf{P}$ 值存在大量错误的解释。人们普遍认为研究的目标是获得显著结果，因此非显著结果意味着研究不成功。这种态度体现在将此类研究结果分别频繁地描述为“阳性”和“阴性”，以及将后者糟糕地描述为“未能达到统计学显著性”。一个可能导致这种扭曲的例子是，将 $\mathbf{P} = 0.05$ 的结果描述为“可能显著”。统计学显著性常被用作解释的唯一依据。因此，任何显著效应，无论多么微小或不可信，都被认为是真实的；而任何非显著效应则被认为表明“没有差异”。以这种方式使用统计数据，就是放弃对结果进行任何建设性思考。  
Erroneous interpretations of 'significant' and 'not significant'  $\mathbf{P}$  values abound. There is a common belief that the goal of research is a significant result, and consequently that a non- significant result implies that the research was unsuccessful. This attitude is seen in the frequent description of such study results as 'positive' and 'negative' respectively, and in the awful description of the latter as having 'failed to reach statistical significance'. An example of the contortion that this may lead to is the description of a result with  $\mathbf{P} = 0.05$  as 'probably significant'. Statistical significance is often used as the sole basis of the interpretation. Thus any significant effect, however small or implausible, is taken as real, and any non- significant effect is taken as indicating that there is 'no difference'. To use statistics in this way is to abdicate from any constructive thought about one's results.  

置信区间的日益广泛使用可能会减少这些困难。几家主要的医学期刊都刊登了支持使用置信区间的社论或文章，有些现在甚至要求作者在主要结果中提供置信区间（Gardner 和 Altman, 1989a）。在比较研究中，重要的是计算组间差异的置信区间，而不是单独计算每组结果的置信区间。  
The increasing use of confidence intervals may reduce the difficulties. Several leading medical journals have carried editorials or articles supporting the use of confidence intervals and some now expect authors to provide them for their main results (Gardner and Altman, 1989a). It is important in comparative studies that confidence intervals are calculated for the difference between groups, not for the results in each group separately.  

在解释结果时，另一个常见的错误是将关联等同于因果关系。正如在几章中讨论的那样，观察到的关联不一定意味着存在因果关系。我们通常可以安全地做出这种推断的唯一研究类型是精心进行的随机对照试验，其中结果的任何差异都可以被认为是与治疗差异有因果关系的。否则，在解释结果时需要非常谨慎，并且通常在没有其他类型证据的情况下无法推断因果关系。当这种错误的推断与观察到的关联本身可能是虚假的情况（如第11.3节所述）结合时，出错的可能性是巨大的。  
The other frequent error in interpretation is to equate association and causation. As discussed in several chapters, an observed association does not necessarily imply that there is a causal relation. The only type of study where we can usually be safe in making such an inference is a well- conducted randomized controlled trial, where any difference in outcome may be taken as causally related to the difference in treatment. Otherwise great caution is needed in the interpretation of results, and causation cannot usually be inferred without other types of evidence. When the false inference is allied to a situation where the observed association itself may be spurious, as described in section 11.3, the scope for error is enormous.  

最后，我必须回到第4.3节中介绍的样本和总体的基本概念。大多数医学研究都基于将样本中的发现推断到感兴趣总体的原则。显然，这项工作关键取决于样本是否具有代表性。理论上，样本应该是一个随机样本，但这几乎从未实现。因此，在实践中，我们需要某种方法来评估样本是否可以被认为是具有代表性的，这通常通过描述样本中受试者的特征，有时将其与总体的已知特征进行比较来完成。如果样本不具有代表性，整个统计推断过程就会失败。这就是为什么高脱落率或拒绝率会严重损害研究结果的原因。  
Lastly, I must return to the basic idea of sample and population introduced in section 4.3. Most medical research is based on the principle of extrapolating findings from a sample to a population of interest. Clearly this exercise is crucially dependent upon the sample being representative of the population. In theory the sample should be a random one, but this is almost never the case. In practice, therefore, we need some way of assessing whether the sample may be considered representative, and this is usually done by means of describing the characteristics of the subjects in the sample, and sometimes comparing them with the known characteristics of the population. The whole process of statistical inference fails if the sample is not representative. This is why study results are heavily compromised by high dropout or refusal rates.  

### 16.3.7 遗漏错误  16.3.7 Errors of omission  

许多文献综述都评论了重要信息被遗漏的频率。如果未明确说明分析方法或设计的关键方面，我们就不应假定使用了有效程序。  
Many reviews of the literature have included comments on how often important information was omitted. If the methods of analysis or key aspects of the design are not specified we should not assume that valid procedures were used.  

Mosteller 等人（1980）检查了132项癌症对照试验，发现只有46项（35%）明确说明了统计分析方法。主要期刊发表的临床试验中，这一数字虽然好得多，达到85%（DerSimonian 等人，1982），但仍有改进空间（另见表16.2）。如果数据是配对的或来自有序类别，了解所用方法是否合适非常重要。如果数据明显不服从正态分布，我们需要确信分析方法是合适的。在更基本的层面上，通常不清楚呈现的是标准差还是标准误。从论文中给出的信息重新分析数据并验证使用了哪种方法，这偶尔才有可能，但本不应如此。  
Mosteller et al. (1980) examined 132 controlled trials in cancer and found that the method of statistical analysis was specified in only 46 (35%). The much better figure of 85% for clinical trials published in major journals (DerSimonian et al., 1982) still leaves scope for improvement (see also Table 16.2). If the data are paired or come from ordered categories it is important to know whether the methods used were appropriate. If the data are clearly not Normally distributed, we need to be assured that the method of analysis was appropriate. At a more basic level it is often unclear whether standard deviations or standard errors are presented. It is only occasionally possible to reanalyse the data from the information given in a paper and so verify which method was used, but this should not be necessary.  

虽然研究设计的总体结构通常在报告中很清楚，但关键细节可能会缺失。通常不清楚所有观察结果是否都来自不同的个体。匹配组的方法可能模糊不清，事实上，当“匹配”组大小不一致（这并不少见）时，我们必须怀疑是否真的使用了匹配。在随机试验中，随机化方法经常被省略。DerSimonian 等人（1992）发现，在他们检查的67项试验中，只有 $19\%$ 报告了随机化方法。这里有两个方面：生成随机数序列的方法，以及分配治疗的机制。很少有论文同时给出两者，而更重要的机制则很少给出（Altman 和 Doré，1990）。我们不能仅仅因为方法部分甚至标题中使用了“随机化”一词（Kuntze 等人，1989），就确信一项试验确实使用了随机分配。验证论文是否包含必要信息的一种方法是使用清单。第16.4节讨论了相关示例。  
While the broad structure of the design of a study is usually clear from the report, crucial details may be missing. It is often unclear if all the observations were taken from different individuals. Methods of matching groups may be vague, and indeed we must doubt if matching was used when, as is not uncommon, the 'matched' groups are not of the same size. In randomized trials, the method of randomization is frequently omitted. DerSimonian et al. (1992) found that the method of randomization was reported in only  $19\%$  of the 67 trials that they examined. There are two aspects here: the method of generating the random number sequence, and the mechanism for allocating the treatments. Few papers give both of them, and the more important mechanism is rarely given (Altman and Doré, 1990). We cannot be sure that a trial really did use random allocation simply from the use of the word 'randomized' somewhere in the methods section, or even in the title (Kuntze et al., 1989).One way to see that a paper contains the necessary information is to use a checklist. Examples are discussed in section 16.4.  

验证论文是否包含必要信息的一种方法是使用清单。第16.4节讨论了相关示例。  
One way to see that a paper contains the necessary information is to use a checklist. Examples are discussed in section 16.4.  

### 16.3.8 统计错误的后果  16.3.8 Consequences of statistical errors  

文献综述通常报告说，约有一半的被审查论文包含统计错误。然而，“错误”一词涵盖了统计纯度方面的各种偏差，许多错误并不严重。在最不重要的层面上，我们可能不会过分担心某些描述性信息以均值形式呈现而没有变异性指示。我们对未说明方法的分析的反应可能取决于所做工作有多“明显”。例如，二乘二频数表几乎肯定是通过卡方检验分析的，但连续数据有许多选项，并非所有选项在任何特定情况下都是合理的。  
Reviews of the literature typically report that about half of the papers examined contained a statistical error. However, the term 'error' encompasses an enormous variety of deviations from statistical purity and many errors will not be serious. At the trivial end we may not worry unduly about the presentation of some descriptive information as means with no indication of variability. Our reaction to an analysis where the method is not stated may depend on how 'obvious' it is what was done. For example, two by two tables of frequencies will almost certainly have been analysed by a Chi squared test, but there are many options for continuous data, not all of which will be reasonable in any particular case.  

评估典型的 $50\%$ 错误率的另一个问题是，对于什么构成错误没有普遍共识。另一方面，还有一些问题在综述中很少被考虑，例如多重比较或仅选择性报告那些显著的结果。  
A further problem in assessing the typical  $50\%$  error rate is that there is no general agreement on what constitutes an error. On the other hand, there are other problems that are rarely considered in reviews, such as multiple comparisons or selective reporting of only those results that are significant.  

在第16.1节中，我列举了统计错误的三种伦理影响：误用患者、浪费资源以及发布误导性结果的后果。其中，最后一项会以多种方式产生影响，并取决于结果的性质：  
In section 16.1 I gave three ethical implications of statistical errors: the misuse of patients, the misuse of resources and the consequences of publishing misleading results. The last of these can work in several ways, and will depend upon the nature of the results:  

1. 即使一项已发表的研究存在缺陷，但由于其发现实验性治疗有益，这可能导致后续研究难以获得伦理委员会的批准；   
1. it may prove impossible to get ethics committee approval to carry out further research because a published study has found the experimental treatment beneficial, even though that study was flawed;   
2. 其他科学家可能会被误导，沿着错误的调查方向进行研究；   
2. other scientists may be led to follow false lines of investigation;   
3. 未来的患者可能会接受次等治疗，这既可能是研究结果的直接  
3. future patients may receive an inferior treatment, either as a direct  

后果，也可能是由于真正有效的治疗方案被延迟引入；4. 如果研究结果未受到质疑，研究人员可能会在未来的研究中继续使用相同的劣质统计方法，而其他人也可能效仿。  
consequence of the results of the study or possibly by the delay in the introduction of a truly effective treatment; 4. if the results go unchallenged the researchers may use the same inferior statistical methods in future research, and others may copy them.  

无论研究是否得出不当结论，上述最后一项问题都适用。  
The last of these applies whether or not the study reached inappropriate conclusions.  

当然，如果每个人都能同样地发现错误，其中一些问题本可以避免，但更好的做法是，期刊能够发现这些错误，并选择不发表论文或进行适当修改。不幸的是，几乎任何论文都可以在某个地方发表，因此，无论期刊如何持续加强其统计审稿，问题仍将存在，对批判性分析的需求也将持续存在。  
Some of these problems would, of course, be avoided if everyone was equally able to detect the errors, but it is much better if they can be detected by journals and the papers either not published or suitably amended. Unfortunately, almost any paper can get published somewhere, so however much journals continue to extend their statistical refereeing the problems will remain, as will the need for critical analysis.  

### 16.3.9 为什么已发表论文中存在如此多的统计错误？  16.3.9 Why are there so many statistical errors in published papers？  

已发表论文中的错误可归因于方法使用者对统计学理解不足，而这反过来又源于统计学教育的不足。本科阶段的统计学教学可以引入一些关键的统计概念，但不足以满足医学研究的需求。多项研究表明，医生对基本统计方法和概念的统计理解不足（Altman and Bland, 1991）。如果简单的概念都未能被很好地理解，我们很难期望更复杂的方法能表现得更好。  
Mistakes in published papers can be ascribed to inadequate understanding of statistics by those using the methods, which in turn is due to inadequate statistical education. Undergraduate teaching of statistics can introduce some of the key statistical concepts, but provides inadequate preparation for the requirements of medical research. Several studies have shown that the statistical understanding by doctors of basic statistical methods and ideas is inadequate (Altman and Bland, 1991). If simple ideas are not well understood, we can hardly expect more complex methods to fare better.  

研究生课程更适合进行深入的统计学教学，但很少有研究人员参加过此类课程。Altman和Bland（1991）还探讨了统计学被广泛误用的其他原因，包括误导性教科书和易于获取的计算机程序。近年来，计算机和统计软件的可用性大幅增加，使得复杂分析方法变得易于获取，但对这些技术的理解并未随之提高。  
Postgraduate courses are more appropriate for in- depth teaching of statistics, but few researchers have attended such a course. Other reasons for the widespread misuse of statistics have been considered by Altman and Bland (1991), and include misleading textbooks and easy access to computer programs. The recent tremendous increase in the availability of computers and statistical software has given wide access to complex methods of analysis, but there has not been an accompanying increase in understanding of those techniques.  

无论原因如何，将无知作为充分的辩护，充其量是值得商榷的。设计和分析的统计方法是严谨医学研究的重要组成部分，其使用需要一定的技能，这与其他研究组成部分同样重要。如果研究团队不具备这些技能，则应通过寻求专家建议来获得。在这方面，我们可以在20世纪30年代再次找到可靠的建议，在布拉德福德·希尔（Bradford Hill）的《柳叶刀》系列文章第一篇的社论中写道：“考虑统计因素的时机是在研究规划阶段，而不是在研究完成后”（Anon，1937）。遗憾的是，许多作者、编辑，甚至伦理委员会，仍然不相信医学研究中正确统计的重要性。因此，有必要  
Whatever the reasons, it is at best questionable whether ignorance is an adequate defence. Statistical methods of design and analysis are an essential component of sound medical research, and their use requires certain skills no less than the other components of the research. If those skills are not present within the research team they should be acquired by seeking expert advice. We can again find sound advice in this respect in the 1930s, in the editorial accompanying the first of Bradford Hill's *Lancet* articles: 'The time to allow for statistical factors is when an inquiry is being planned, not when it is completed' (Anon, 1937). Sadly many authors, editors, and even ethics committees remain unconvinced about the importance of correct statistics in medical research. Thus it is necessary to read  

带着一定的审慎态度阅读已发表的论文，即使是那些发表在最著名期刊上的论文。第16.4节提供了如何做到这一点的建议。  
published papers with some circumspection, even those published in the most illustrious journals. Section 16.4 gives advice on how to do this.  

### 16.3.10 医学期刊的作用  16.3.10 Role of the medical journals  

不言而喻，如果期刊停止发表包含重大错误的论文，已发表论文的统计学水平将大大提高。尽管有证据表明统计学审稿可以提高已发表论文的水平，但期刊总体上在判断投稿论文的统计学部分方面进展缓慢。事实仍然是，大多数期刊的作者须知对参考文献排版方式的关注远远超过对所需统计信息的关注，而且大多数甚至没有提及统计学。无论喜欢与否，期刊都有责任发表在可判断范围内科学严谨的论文。医学文献的质量掌握在它们的编辑手中。  
It is self- evident that the standard of statistics in published papers could be greatly raised if journals ceased publishing papers containing major errors. Despite evidence that statistical refereeing can improve the standard of published papers, journals have in general been slow to take steps to judge the statistical component of submitted papers. It is still true that most journals' instructions to authors give far more attention to how the references are laid out than to what statistical information is required, and most do not even mention statistics. Like it or not, journals have a responsibility for publishing papers that are, as far as can be judged, scientifically sound. The quality of the medical literature is in their editorial hands.  

由于期刊编辑人员中很少有人比论文作者更懂统计学，因此统计学专业知识必须通过专家审稿来获得。在最近的一项调查中，向98位医学期刊编辑询问了他们关于统计学审稿的政策，并从83位编辑那里获得了回复（George，1985）。只有$16\%$的期刊有政策保证在出版前进行统计学审查，但有$35\%$的期刊设有统计学顾问或编辑委员会中有统计学家。在这方面显然有很大的改进空间（Altman，1982c），尽管必须承认，可能没有足够的医学统计学家来审阅所有提交给医学期刊的论文。然而，我相信所有期刊都应该努力获得一些统计学方面的投入。此外，他们应该公布其关于统计学审稿的编辑政策，而上述调查中只有$12\%$的期刊做到了这一点。  
As few members of the editorial staff of journals are likely to know much more statistics than the authors of papers, the statistical expertise must be obtained through expert refereeing. In a recent survey, 98 editors of medical journals were asked about their policy on statistical refereeing and replies were obtained from 83 (George, 1985). Only  $16\%$  had a policy that guaranteed a statistical review prior to publication, but  $35\%$  had either a statistical consultant or a statistician on the editorial board. There is clearly considerable scope for improvement in this respect (Altman, 1982c), although it must be acknowledged that there are probably not enough medical statisticians to look at all papers submitted to medical journals. Nevertheless, I believe that all journals should endeavour to obtain some statistical input. Further, they should publish their editorial policy regarding statistical refereeing, something which only  $12\%$  of the journals in the above- mentioned survey had done.  

短期内，除了少数期刊外，统计学水平不太可能出现大的改善，因此，作为已发表论文的读者，保持谨慎至关重要。你不应该仅仅根据论文的摘要就接受研究结果，而应该仔细评估作者的方法。下一节将提供一些指导。  
It is most unlikely that there will be a great improvement in the short term except perhaps in a few journals, so it is important to be a cautious reader of published papers. You should not accept research findings solely on the basis of the abstract of a paper, but rather should make a careful assessment of the authors' methods. Some guidance is given in the next section.  

## 16.4 阅读科学论文  16.4 READING A SCIENTIFIC PAPER  

在阅读论文时，如果能有一份需要注意的具体事项清单，将非常有帮助。正如Colton（1974，第317页）所指出的，不可能制定出一套适用于所有研究论文的  
It is enormously helpful when reading a paper to have a list of specific points to be looking out for. As noted by Colton (1974, p. 317), it is impossible to produce a set of questions that it would be appropriate to ask  

问题。一个部分解决方案是拥有不止一套清单；例如，Gardner等人（1989）为统计审稿人制作了两份清单，一份用于一般医学研究，另一份专门用于临床试验。其他作者提出了阅读临床试验报告的指南（Simon和Wittes，1985；Grant，1989；Reisch等人，1989）、流行病学研究（包括病例对照研究）（Epidemiology Work Group，1981；Lichtenstein等人，1987；Bracken，1989），以及诊断和筛查试验的评估（Sheps和Schechter，1984；Wald和Cuckle，1989）。  
for every research paper. A partial solution is to have more than one; for example, Gardner et al. (1989) produced two checklists for statistical reviewers, one for general medical studies and one specifically for clinical trials. Other authors have proposed guidelines for reading reports on clinical trials (Simon and Wittes, 1985; Grant, 1989; Reisch et al., 1989), epidemiological studies including case- control studies (Epidemiology Work Group, 1981; Lichtenstein et al., 1987; Bracken, 1989), and evaluation of diagnostic and screening tests (Sheps and Schechter, 1984; Wald and Cuckle, 1989).  

我将沿用为一般研究和临床试验提供两份不同清单的思路。图16.1和图16.2所示的清单主要基于Gardner等人（1989）的清单，但加入了一些扩展和澄清。它们旨在帮助《英国医学杂志》投稿论文的统计审稿，但同样适用于评估已发表的论文。  
I shall follow the idea of having two different checklists for general studies and for clinical trials. Those shown in Figures 16.1 and 16.2 are heavily based on those in Gardner et al. (1989), but incorporate some extensions and clarifications. They were designed to aid the statistical refereeing of papers submitted to the British Medical Journal, but are equally applicable for assessing papers already published.  

图16.1中的问题可用于评估临床试验以外的医学论文。大多数问题与研究设计和数据分析的重要方面有关。图16.2显示了评估临床试验报告的核对表。这些问题与前一章中详细讨论的设计和分析方面有关。设计中特别重要的方面涉及对消除偏倚可能性的努力的描述。如前所述，如果相关信息缺失，我们无法推断某个程序已被采用。例如，常见的是看到论文将试验描述为随机和双盲，但如果除了这三个词之外没有任何信息，我们不应假定作者理解这些术语。将交替分配方法描述为随机是很常见的；当然，这与随机是完全不同的，而且明显劣势。Chalmers 等人（1981）提出了一种更为详细的临床试验评估方案。  
The questions in Figure 16.1 can be used to assess medical papers other than clinical trials. Most of the questions relate to important aspects of the design of the study and analysis of the data. Figure 16.2 shows a checklist for assessing reports of clinical trials. The questions relate to aspects of design and analysis that were discussed at length in the previous chapter. Aspects of design of particular importance relate to the description of efforts to eliminate the possibility of bias. As noted already, we cannot infer that a procedure was adopted if the relevant information is absent. For example, it is common to see papers describing trials as both randomized and double blind, but in the absence of any information beyond those three words we should not assume that the authors understand those terms. It is quite common to see methods of alternate allocation described as random; it is, of course, quite different and definitely inferior. A much more detailed assessment scheme for clinical trials was proposed by Chalmers et al. (1981).  

需要注意的是，核对表中的许多问题都没有明确的答案，因此评估一篇论文涉及一定的主观性。尽管如此，使用这些（或其他）核对表使得评估论文变得容易得多，部分原因是发现遗漏总是比发现现有错误更困难。  
It will be appreciated that for many of the questions in the checklists there is no unequivocal answer, and assessing a paper thus involves some subjectivity. Nevertheless, the use of these (or other) checklists makes it much easier to assess a paper, partly because it is always harder to detect omissions than errors in what is present.  

核对表中的问题并非同等重要。理想情况下，我们希望所有问题都能得到“是”的回答，但很少有论文能做到这一点。实际上，我们最应该关注的是研究设计中可能存在的偏倚。确实，如果研究设计因某种原因不可接受，那么无论数据如何分析，该论文在统计上都是不可接受的。其次，我们希望分析方法与数据相符，并且结论是合理的。呈现方面虽然并非不重要，但显然不如方法学的基本方面重要。  
The questions in the checklists are not equally important. Ideally we would like to see 'Yes' responses for all questions but few papers will achieve this. In practice we should be most concerned about possible bias in the design of the study. Indeed, if the design of the study is unacceptable for some reason, the paper is statistically unacceptable regardless of how the data were analysed. Next we would hope that the analysis was appropriate to the data, and that the conclusions were justified. Aspects of presentation, while not unimportant, are clearly less important than fundamental aspects of methodology.  

### 研究设计  STUDY DESIGN  

研究目标是否充分描述？ 是 不清楚 否  
Is the objective of the study sufficiently described？ Yes Unclear No  

研究设计是否充分描述？ 是 不清楚 否  
Is the design of the study sufficiently described？ Yes Unclear No  

研究设计是否与目标相符？ 是 不清楚 否  
Was the design of the study appropriate to the Yes Unclear No objective？  

受试者来源是否清晰描述？ 是 不清楚 否  
Is the source of the subjects clearly described？ Yes Unclear No  

受试者选择方法（即纳入和排除标准）是否清晰描述？ 是 不清楚 否  
Is the method of selection of the subjects clearly Yes Unclear No described (i.e. inclusion and exclusion criteria)？  

受试者样本是否与研究结果将引用的总体相符？ 是 不清楚 否  
Was the sample of subjects appropriate with Yes Unclear No regard to the population to which the findings will be referred？  

样本量是否基于研究前对统计功效 Yes 不清楚 否 的考虑？  
Was the sample size based on pre- study Yes Unclear No considerations of statistical power？  

研究设计是否可接受？ 是 否  
Is the design of the study acceptable？ Yes No  

### 研究实施  CONDUCT OF STUDY  

是否达到了令人满意的（高）回应率？ 是 不清楚 否  
Was a satisfactory (high) response rate achieved？ Yes Unclear No  

### 分析与呈现  ANALYSIS AND PRESENTATION  

是否有充分描述或引用所有使用的统计 是 否 程序的声明？  
Is there a statement adequately describing or Yes No referencing all the statistical procedures used？  

所使用的统计方法是否适用于数据？ 是 不清楚 否  
Were the statistical methods used appropriate for Yes Unclear No the data？  

它们是否使用正确？ 是 不清楚 否  
Were they used correctly？ Yes Unclear No  

统计材料（表格、图表、数值）的呈现 是 否 是否令人满意？  
Is the presentation of statistical material (tables, Yes No graphical, numerical) satisfactory？  

是否呈现了足够的分析？ 是 不清楚 否  
Are sufficient analyses presented？ Yes Unclear No  

主要结果是否给出了置信区间？ 是 否  
Are confidence intervals given for the main Yes No results？  

### 总体评估  OVERALL ASSESSMENT  

统计分析得出的结论是否合理？ 是 不明确 否  
Are the conclusions drawn from the statistical Yes Unclear No analyses justified？  

该文章在统计学上是否可接受？ 是 否  
Is the paper statistically acceptable？ Yes No  

图 16.1 普通医学文章评估核对表。  
Figure 16.1 Checklist for assessment of general medical papers.  

### 研究设计  STUDY DESIGN  

试验目的是否充分描述？ 是 不明确 否  
Is the objective of the trial sufficiently Yes Unclear No described？  

研究设计是否充分描述？ 是 不明确 否  
Is the design of the study sufficiently Yes Unclear No described？  

是否有令人满意的入组诊断标准说明？ 是 不明确 否  
Is there a satisfactory statement of the Yes Unclear No diagnostic criteria for entry into the trial？  

受试者来源是否清晰描述？ 是 不明确 否  
Is the source of the subjects clearly Yes Unclear No described？  

治疗方法是否明确定义？是 不确定 否  
Were the treatments well defined？ Yes Unclear No  

治疗组是否同时进行研究？是 不确定 否  
Were the treatment groups studied Yes Unclear No concurrently？  

是否使用了随机分配治疗？是 不确定 否  
Was random allocation to treatment used？ Yes Unclear No  

是否描述了创建随机化的方法（例如随机数表）？是 不确定 否  
Is the method of creating the randomisation Yes Unclear No (e.g. tables of random numbers) described？  

是否描述了治疗分配的机制（例如密封信封）？是 不确定 否  
Is the mechanism of treatment allocation Yes Unclear No (e.g. sealed envelopes) described？  

治疗分配机制是否旨在消除偏倚？是 不确定 否  
Was the mechanism of treatment allocation Yes Unclear No designed to eliminate bias？  

从分配到开始治疗的延迟是否可接受地短？是 不确定 否  
Was there an acceptably short delay from Yes Unclear No allocation to commencement of treatment？  

试验期间是否使用了潜在的盲法程度？是 不确定 否  
Was the potential degree of blindness used Yes Unclear No during the trial？  

是否有关于结局测量标准的满意说明？是 不确定 否  
Is there a satisfactory statement of criteria Yes Unclear No for outcome measures？  

结局测量是否恰当？是 不确定 否  
Are the outcome measures appropriate？ Yes Unclear No  

是否有描述基于统计功效考虑的预研究样本量计算？ 是 否  
Is there a description of a pre- study Yes No calculation of sample size based on considerations of statistical power？  

是否说明了治疗后随访的持续时间？ 是 不明确 否  
Is the duration of post- treatment follow- up Yes Unclear No stated？  

研究设计是否可接受？ 是 否  
Is the design of the study acceptable？ Yes No  

### 研究实施  CONDUCT OF STUDY  

是否有高比例受试者完成随访？ 是 不明确 否  
Were a high proportion of subjects followed Yes Unclear No up？  

是否有高比例受试者完成治疗？ 是 不明确 否  
Did a high proportion of subjects complete Yes Unclear No treatment？  

是否分别描述了每个治疗组的脱落者？ 是 不明确 否  
Are drop- outs described separately for each Yes Unclear No treatment group？  

是否分别描述了每个组的治疗副作用？ 是 不明确 否  
Are side- effects of treatment described Yes Unclear No separately for each group？  

### 分析与呈现  ANALYSIS AND PRESENTATION  

是否有充分描述或引用所有使用的统计程序的声明？ 是 否  
Is there a statement adequately describing Yes No or referencing all the statistical procedures used？  

各组的基线特征是否已充分呈现？ 是 否  
Are the baseline characteristics of each Yes No group presented adequately？  

所使用的统计方法是否适用于数据？ 是 不确定 否  
Were the statistical methods used Yes Unclear No appropriate for the data？  

它们是否被正确使用？ 是 不确定 否  
Were they used correctly？ Yes Unclear No  

预后因素是否已充分考虑？ 是 不确定 否  
Have prognostic factors been adequately Yes Unclear No considered？  

统计资料（表格、图表、数值）的呈现是否令人满意？ 是 否  
Is the presentation of statistical material Yes No (tables, graphical, numerical) satisfactory？  

是否呈现了充分的分析？ 是 不确定 否  
Are sufficient analyses presented？ Yes Unclear No  

主要结果是否给出了置信区间？ 是 否  
Are confidence intervals given for the main Yes No results？  

### 总体评估  OVERALL ASSESSMENT  

从统计分析中得出的结论是否合理？ 是 不确定 否  
Are the conclusions drawn from the Yes Unclear No statistical analyses justified？  

该论文在统计学上是否可接受？ 是 否  
Is the paper statistically acceptable？ Yes No  

图16.2 临床试验报告评估核对表。  
Figure 16.2 Checklist for assessment of reports of clinical trials.  

## 16.5 撰写科学论文  16.5 WRITING A SCIENTIFIC PAPER  

医学期刊在论文的统计学方面给作者的指导甚少。显然，阅读论文和撰写论文的某些方面有许多相似之处，图16.1和图16.2中的核对表应能很好地说明论文中应包含的信息类型。Altman 等人（1989）为作者提供了一套更为全面的指南，涵盖了统计学的所有方面。关于研究的统计学方面，应遵循的基本原则是：方法应描述得足够详细，以便完全理解，并且任何拥有原始数据的人，如果愿意，都可以重现你的结果。更简单地说，你应该清楚地描述你所做的每一步。  
Medical journals give authors scant guidance regarding the statistical aspects of papers. Clearly there is much similarity between aspects of reading a paper and those of writing a paper, and the checklists in Figures 16.1 and 16.2 should give a good idea of the type of information that should be included in a paper. A much more comprehensive set of guidelines for authors is given by Altman et al. (1989), covering all aspects of statistics. The basic principle to be adhered to with respect to the statistical aspects of your research is that the methods should be described in sufficient detail to be fully understood, and so that anyone else with access to your raw data could, if desired, reproduce your results. Put more simply, you should describe clearly exactly what was done.  

如果你的研究有一个有用的目标，你采用了合理的设计和足够的样本量，你进行了适当的分析并从你的发现中得出了合理的推论，那么你的论文应该能够在好的期刊上发表。最重要的方面无疑是设计，因为数据总是可以重新分析的。虽然我希望读完这本书后，你将能够对你的数据进行合理的分析，但你可以从以下评论中得到慰藉：  
If your research had a useful objective, you have used a sensible design and adequate sample size, you have performed appropriate analyses and drawn reasonable inferences from your findings you should be able to get your paper published in a good journal. The most important aspect is unquestionably the design, because it is always possible to reanalyse your data. While I hope that after reading this book you will be able to carry out sensible analyses of your data, you may take comfort from the following comment:  

我记不起在担任一份主要同行评审期刊编辑的六年里，我曾仅仅因为统计计算错误而拒绝一篇论文，但很大一部分的拒稿是由于统计设计和概念上更根本的问题，这些问题事后很少能补救。  
I cannot recall that during six years as editor of a major peer- reviewed journal I ever turned down a paper solely because statistical computations were in error, but a large proportion of disapprovals resulted from more fundamental problems of statistical design and concept, which can rarely be remedied after the fact.  

（Bailar, 1986）  
(Bailar, 1986)  

统计学是一个相对较新的领域，和医学一样，它也受时尚的影响。近年来，许多领先的医学期刊在政策上发生了重大转变，鼓励甚至要求作者在呈现主要结果时使用置信区间。这些方法已经存在了几十年，但直到最近才在医学领域被接受。也许这一过程的延续将是假设检验以及装饰大多数医学研究论文的过多 $\mathbf{P}$ 值和星号的使用减少（Evans et al., 1988）。我不会预测这样的发展，但未来几年医学期刊中统计学的使用似乎很可能发生进一步变化。我希望我们将开始看到重要统计错误的频率普遍减少，这些错误的存在损害了文献的完整性，并最终可能导致对患者的不利后果。由于监管机构的要求，评估新药的研究的统计质量受到了显著影响，现在有迹象表明，对  
Statistics is a relatively new field, and like medicine is subject to fashion. In recent years there has been a major shift in policy by many leading medical journals towards encouraging or even requiring authors to use confidence intervals when presenting their main results. The methods have been around for many decades, but have only belatedly become accepted in medicine. Perhaps a continuation of this process would be a decline in the use of hypothesis tests and the plethora of  $\mathbf{P}$  values and asterisks that adorn most medical research papers (Evans et al., 1988). I shall not predict such a development, but it seems likely that the next few years will see further changes in the use of statistics in medical journals. My hope is that we will begin to see a widespread reduction in the frequency of important statistical errors, whose presence compromises the integrity of the literature and may, ultimately, lead to adverse consequences for patients. Following the marked effect on the statistical quality of studies evaluating new drugs as a result of requirements of the regulatory authorities, there are signs of a more widespread increase in awareness of the importance of  

良好设计和正确分析重要性的认识正在更广泛地提高。为此，我希望在这本书中，我成功地传达了医学研究统计学部分所依据的重要概念。例如，记住比例的置信区间公式（或任何公式）并不重要—你总是可以查阅。重要的是理解置信区间的含义。更普遍的是，理解研究设计和统计推断背后的关键统计概念至关重要。  
good design and correct analysis. To this end I hope that in this book I have succeeded in getting across the important concepts that underlie the statistical component of medical research. For example, it is not important to remember the formula for the confidence interval for a proportion (or any formula for that matter) - you can always look it up. It is important to understand what the confidence interval means. More generally it is essential to understand the key statistical concepts underlying study design and statistical inference.  

我将以Mainland（1950）的一些评论作为结束，他是一位解剖学家，后来也成为统计学教授。这些评论至今仍像他写下时那样具有现实意义：  
I shall close with some comments of Mainland (1950), an anatomist who subsequently became a professor of statistics too. They are still as relevant as when he wrote them:  

最后，必须再次强调，无论找到何种帮助来源，无论采用何种技术，研究者本人都必须掌握统计推理的原则……现代统计原则并非我们可以随意取舍的东西，因为它们构成了所有领域（包括临床研究领域）研究者的逻辑。  
Finally, it must be stressed again that, whatever sources of help are found and whatever techniques are employed, the investigator himself has to grasp the principles of statistical reasoning … modern statistical principles are not something that we can take or leave as we wish, for they comprise the logic of the investigator in all fields, including the field of clinical research.  

## 习题  EXERCISES  

（这些问题不限于本章内容。）  
(These problems are not specific to the material in this chapter.)  

16.1 如果两项研究的结果分别为 $\mathbf{P}< 0.001$ 和 $\mathbf{P} = 0.02$ ，为什么，正如第16.3.6节所指出的，前者的效应比后者更强这一说法不一定正确？  
16.1 If two studies' results yield  $\mathbf{P}< 0.001$  and  $\mathbf{P} = 0.02$ , why is it not necessarily true, as noted in section 16.3.6, that the former has found a stronger effect than the latter？  

16.2 如果两项相同的研究结果分别为 $\mathbf{P}< 0.001$ 和 $\mathbf{P} = 0.2$ ，这种巨大差异的可能解释是什么？  
16.2 If two identical studies yield  $\mathbf{P}< 0.001$  and  $\mathbf{P} = 0.2$ , what are the possible explanations for the large difference？  

16.3 某人群中成年男性和女性身高的均值和标准差（单位：厘米）如下：  
16.3 The mean and standard deviation of the heights (in cm) of adult men and women in a population are as follows  

<table><tr><td></td><td>均值</td><td>标准差</td></tr><tr><td>男性</td><td>179.1</td><td>5.84</td></tr><tr><td>女性</td><td>171.7</td><td>5.75</td></tr></table>  
<table><tr><td></td><td>Mean</td><td>SD</td></tr><tr><td>Men</td><td>179.1</td><td>5.84</td></tr><tr><td>Women</td><td>171.7</td><td>5.75</td></tr></table>  

假设男女身高都服从正态分布，  
Assuming that for both sexes height has a Normal distribution,  

(a) 身高高于男性平均身高的女性占多大比例？  
(a) What proportion of women are above the average height of men？  

(b) 如果成年人中有 $60\%$ 是女性，那么身高超过 $182.9 \mathrm{cm}$（六英尺）的成年人中女性占多大比例？  
(b) If  $60\%$  of adults are female, what proportion of adults taller than  $182.9 \mathrm{cm}$  (six feet) are women？  

16.4 下表显示了1931-5年和1983年英格兰和威尔士女性每1000人的年龄别和总年度死亡率（数据来源：  
16.4 The following table shows age- specific and total annual death rates per 1000 females in England and Wales in 1931- 5 and 1983 (Office of  

人口普查和调查死亡率统计）。  
Population Censuses and Surveys Mortality Statistics).  

<table><tr><td rowspan="2">年龄</td><td colspan="2">年死亡率/1000人</td></tr><tr><td>1931–5</td><td>1983</td></tr><tr><td>&amp;lt; 1</td><td>54</td><td>9</td></tr><tr><td>1– 4</td><td>6.2</td><td>0.4</td></tr><tr><td>5– 9</td><td>2.1</td><td>0.2</td></tr><tr><td>10–14</td><td>1.4</td><td>0.2</td></tr><tr><td>15–19</td><td>2.2</td><td>0.3</td></tr><tr><td>20–24</td><td>2.8</td><td>0.3</td></tr><tr><td>25–34</td><td>3.1</td><td>0.5</td></tr><tr><td>35–44</td><td>4.3</td><td>1.2</td></tr><tr><td>45–54</td><td>8.0</td><td>3.6</td></tr><tr><td>55–64</td><td>17</td><td>10</td></tr><tr><td>65–74</td><td>43</td><td>24</td></tr><tr><td>75–84</td><td>109</td><td>64</td></tr><tr><td>85+</td><td>245</td><td>176</td></tr><tr><td>所有年龄</td><td>11.4</td><td>11.4</td></tr></table>  
<table><tr><td rowspan="2">Age</td><td colspan="2">Annual death rates/1000</td></tr><tr><td>1931–5</td><td>1983</td></tr><tr><td>&amp;lt; 1</td><td>54</td><td>9</td></tr><tr><td>1– 4</td><td>6.2</td><td>0.4</td></tr><tr><td>5– 9</td><td>2.1</td><td>0.2</td></tr><tr><td>10–14</td><td>1.4</td><td>0.2</td></tr><tr><td>15–19</td><td>2.2</td><td>0.3</td></tr><tr><td>20–24</td><td>2.8</td><td>0.3</td></tr><tr><td>25–34</td><td>3.1</td><td>0.5</td></tr><tr><td>35–44</td><td>4.3</td><td>1.2</td></tr><tr><td>45–54</td><td>8.0</td><td>3.6</td></tr><tr><td>55–64</td><td>17</td><td>10</td></tr><tr><td>65–74</td><td>43</td><td>24</td></tr><tr><td>75–84</td><td>109</td><td>64</td></tr><tr><td>85+</td><td>245</td><td>176</td></tr><tr><td>All ages</td><td>11.4</td><td>11.4</td></tr></table>  

在过去的五十年里，每个年龄组的死亡率都大幅下降。那么，如何解释所有年龄段女性每1000人的总死亡率保持不变这一事实呢？  
Over the fifty years there was a large decline in the death rate in every age group. What would explain the fact that the overall death rate per 1000 women of all ages was unchanged？  

16.5 下表显示了五岁儿童中，龋齿、缺失或充填牙齿数量达到五颗或更多的百分比 $(\% \mathrm{dmft})$，按社会阶层划分，并分别针对持续居住在氟化水地区或附近非氟化水地区的儿童（Carmichael 等人，1989）进行统计。  
16.5 The following table shows the percentage of five year olds with five or more decayed, missing or filled teeth  $(\% \mathrm{dmft})$  by social class, separately for children who had lived continuously in either an area with fluoridated water or in a nearby non- fluoridated area (Carmichael et al., 1989).  

<table><tr><td>社会阶层</td><td>氟化水地区</td><td>% dmft   
<table><tr><td>Social class</td><td>Fluoridated</td><td>% dmft   
非氟化水地区</td></tr><tr><td>I-II</td><td>10</td><td>21</td></tr><tr><td>III</td><td>15</td><td>33</td></tr><tr><td>IV-V</td><td>21</td><td>45</td></tr><tr><td>未分类</td><td>20</td><td>47</td></tr></table>  
Non-fluoridated</td></tr><tr><td>I-II</td><td>10</td><td>21</td></tr><tr><td>III</td><td>15</td><td>33</td></tr><tr><td>IV-V</td><td>21</td><td>45</td></tr><tr><td>Unclassified</td><td>20</td><td>47</td></tr></table>  

(a) 使用卡方检验比较两个地区按社会阶层划分的 $\%$ dmft 是否合理？  
(a) Is it reasonable to use a Chi squared test to compare  $\%$  dmft by social class in the two areas？  

(b) 实际儿童人数如下：  
(b) The actual numbers of children were as follows:  

<table><tr><td>社会阶层</td><td>氟化水地区</td><td>dmft   
<table><tr><td>Social class</td><td>Fluoridated</td><td>dmft   
非氟化水地区</td></tr><tr><td>I-II</td><td>12/117</td><td>12/ 56</td></tr><tr><td>III</td><td>26/170</td><td>48/146</td></tr><tr><td>IV-V</td><td>11/ 52</td><td>29/ 64</td></tr><tr><td>未分类</td><td>24/118</td><td>49/104</td></tr><tr><td>总计</td><td>73/457</td><td>138/370</td></tr></table>  
Non-fluoridated</td></tr><tr><td>I-II</td><td>12/117</td><td>12/ 56</td></tr><tr><td>III</td><td>26/170</td><td>48/146</td></tr><tr><td>IV-V</td><td>11/ 52</td><td>29/ 64</td></tr><tr><td>Unclassified</td><td>24/118</td><td>49/104</td></tr><tr><td>Total</td><td>73/457</td><td>138/370</td></tr></table>  

计算两个区域儿童总组别中龋失补牙（$\%$ dmft）差异的 $95\%$ 置信区间。  
Calculate a  $95\%$  confidence interval for the difference in  $\%$  dmft in the total groups of children in the two areas.  

(c) 在这两个区域内，龋失补牙（$\%$ dmft）与社会阶层之间是否存在显著关系？  
(c) Is there a significant relation between  $\%$  dmft and social class within each of the two areas？  

(d) 我们如何评估在非氟化区域中这种关系是否比在氟化区域中更强？  
(d) How might we assess whether the relation is stronger in the non-fluoridated than the fluoridated area？  

(e) 这种效应的名称是什么？  
(e) What is the name for such an effect？  

16.6 对50名孕妇的收缩压（SBP）进行了测量，同时在同一手臂上使用动脉内测量（直接法）和血压计（间接法）进行（Raftery和Ward，1968）。测量了臂围和体重，因为有迹象表明它们可能影响这两种测量方法之间的差异。数据如下表所示：  
16.6 The systolic blood pressure (SBP) of 50 pregnant women was measured simultaneously in the same arm using intra- arterial measurement (direct) and a sphygmomanometer (indirect) (Raftery and Ward, 1968). Arm circumference and weight were measured because there was some suggestion that they might affect the difference between the two measurements. The data are shown in the following table:  

<table><tr><td>年龄</td><td>体重 (kg)</td><td>臂围 (cm)</td><td>间接收缩压 (mm Hg)</td><td>差值 (I-D)</td></tr><tr><td>1</td><td>32</td><td>78.2</td><td>29</td><td>115</td></tr><tr><td>2</td><td>25</td><td>67.8</td><td>25</td><td>122</td></tr><tr><td>3</td><td>35</td><td>71.7</td><td>26</td><td>118</td></tr><tr><td>4</td><td>41</td><td>60.8</td><td>24</td><td>127</td></tr><tr><td>5</td><td>30</td><td>78.7</td><td>33</td><td>110</td></tr><tr><td>6</td><td>29</td><td>87.8</td><td>31</td><td>146</td></tr><tr><td>7</td><td>20</td><td>68.9</td><td>26</td><td>127</td></tr><tr><td>8</td><td>38</td><td>70.5</td><td>25</td><td>126</td></tr><tr><td>9</td><td>31</td><td>68.0</td><td>29</td><td>81</td></tr><tr><td>10</td><td>39</td><td>72.6</td><td>28</td><td>127</td></tr><tr><td>11</td><td>36</td><td>53.3</td><td>31</td><td>127</td></tr><tr><td>12</td><td>23</td><td>53.3</td><td>23</td><td>80</td></tr><tr><td>13</td><td>25</td><td>46.0</td><td>22</td><td>89</td></tr></table>  
<table><tr><td>Age</td><td>Weight (kg)</td><td>Arm circumference (cm)</td><td>Systolic BP indirect (mm Hg)</td><td>Diff (I-D)</td></tr><tr><td>1</td><td>32</td><td>78.2</td><td>29</td><td>115</td></tr><tr><td>2</td><td>25</td><td>67.8</td><td>25</td><td>122</td></tr><tr><td>3</td><td>35</td><td>71.7</td><td>26</td><td>118</td></tr><tr><td>4</td><td>41</td><td>60.8</td><td>24</td><td>127</td></tr><tr><td>5</td><td>30</td><td>78.7</td><td>33</td><td>110</td></tr><tr><td>6</td><td>29</td><td>87.8</td><td>31</td><td>146</td></tr><tr><td>7</td><td>20</td><td>68.9</td><td>26</td><td>127</td></tr><tr><td>8</td><td>38</td><td>70.5</td><td>25</td><td>126</td></tr><tr><td>9</td><td>31</td><td>68.0</td><td>29</td><td>81</td></tr><tr><td>10</td><td>39</td><td>72.6</td><td>28</td><td>127</td></tr><tr><td>11</td><td>36</td><td>53.3</td><td>31</td><td>127</td></tr><tr><td>12</td><td>23</td><td>53.3</td><td>23</td><td>80</td></tr><tr><td>13</td><td>25</td><td>46.0</td><td>22</td><td>89</td></tr></table>  

<table><tr><td>年龄</td><td>体重 (kg)</td><td>臂围 (cm)</td><td>间接收缩压 (mm Hg)</td><td>差值 (I-D)</td></tr><tr><td>14</td><td>35</td><td>65.9</td><td>26</td><td>136</td></tr><tr><td>15</td><td>26</td><td>68.0</td><td>26</td><td>105</td></tr><tr><td>16</td><td>23</td><td>73.0</td><td>29</td><td>99</td></tr><tr><td>17</td><td>19</td><td>65.6</td><td>26</td><td>129</td></tr><tr><td>18</td><td>21</td><td>59.9</td><td>25</td><td>98</td></tr><tr><td>19</td><td>31</td><td>77.8</td><td>29</td><td>115</td></tr><tr><td>20</td><td>30</td><td>82.0</td><td>31</td><td>169</td></tr><tr><td>21</td><td>39</td><td>65.8</td><td>26</td><td>107</td></tr><tr><td>22</td><td>30</td><td>63.5</td><td>25</td><td>166</td></tr><tr><td>23</td><td>35</td><td>63.6</td><td>28</td><td>93</td></tr><tr><td>24</td><td>34</td><td>73.6</td><td>27</td><td>115</td></tr><tr><td>25</td><td>30</td><td>62.1</td><td>25</td><td>93</td></tr><tr><td>26</td><td>26</td><td>81.1</td><td>33</td><td>118</td></tr><tr><td>27</td><td>29</td><td>70.5</td><td>30</td><td>116</td></tr><tr><td>28</td><td>27</td><td>65.8</td><td>26</td><td>111</td></tr><tr><td>29</td><td>19</td><td>77.6</td><td>31</td><td>159</td></tr><tr><td>30</td><td>21</td><td>58.1</td><td>24</td><td>110</td></tr><tr><td>31</td><td>44</td><td>76.2</td><td>24</td><td>93</td></tr><tr><td>32</td><td>20</td><td>58.4</td><td>25</td><td>93</td></tr><tr><td>33</td><td>33</td><td>59.2</td><td>28</td><td>117</td></tr><tr><td>34</td><td>41</td><td>59.8</td><td>27</td><td>120</td></tr><tr><td>35</td><td>28</td><td>54.9</td><td>23</td><td>114</td></tr><tr><td>36</td><td>28</td><td>79.4</td><td>28</td><td>132</td></tr><tr><td>37</td><td>18</td><td>64.9</td><td>26</td><td>157</td></tr><tr><td>38</td><td>18</td><td>67.6</td><td>25</td><td>109</td></tr><tr><td>39</td><td>32</td><td>61.0</td><td>27</td><td>157</td></tr><tr><td>40</td><td>20</td><td>87.0</td><td>43</td><td>126</td></tr><tr><td>41</td><td>21</td><td>51.5</td><td>23</td><td>83</td></tr><tr><td>42</td><td>31</td><td>81.6</td><td>29</td><td>116</td></tr><tr><td>43</td><td>29</td><td>72.1</td><td>31</td><td>158</td></tr><tr><td>44</td><td>21</td><td>95.3</td><td>31</td><td>118</td></tr><tr><td>45</td><td>28</td><td>74.2</td><td>28</td><td>123</td></tr><tr><td>46</td><td>22</td><td>79.6</td><td>27</td><td>154</td></tr><tr><td>47</td><td>20</td><td>70.5</td><td>26</td><td>126</td></tr><tr><td>48</td><td>28</td><td>79.5</td><td>26</td><td>119</td></tr><tr><td>49</td><td>19</td><td>60.9</td><td>24</td><td>73</td></tr><tr><td>50</td><td>20</td><td>77.6</td><td>27</td><td>116</td></tr></table>  
<table><tr><td>Age</td><td>Weight (kg)</td><td>Arm circumference (cm)</td><td>Systolic BP indirect (mm Hg)</td><td>Diff (I-D)</td></tr><tr><td>14</td><td>35</td><td>65.9</td><td>26</td><td>136</td></tr><tr><td>15</td><td>26</td><td>68.0</td><td>26</td><td>105</td></tr><tr><td>16</td><td>23</td><td>73.0</td><td>29</td><td>99</td></tr><tr><td>17</td><td>19</td><td>65.6</td><td>26</td><td>129</td></tr><tr><td>18</td><td>21</td><td>59.9</td><td>25</td><td>98</td></tr><tr><td>19</td><td>31</td><td>77.8</td><td>29</td><td>115</td></tr><tr><td>20</td><td>30</td><td>82.0</td><td>31</td><td>169</td></tr><tr><td>21</td><td>39</td><td>65.8</td><td>26</td><td>107</td></tr><tr><td>22</td><td>30</td><td>63.5</td><td>25</td><td>166</td></tr><tr><td>23</td><td>35</td><td>63.6</td><td>28</td><td>93</td></tr><tr><td>24</td><td>34</td><td>73.6</td><td>27</td><td>115</td></tr><tr><td>25</td><td>30</td><td>62.1</td><td>25</td><td>93</td></tr><tr><td>26</td><td>26</td><td>81.1</td><td>33</td><td>118</td></tr><tr><td>27</td><td>29</td><td>70.5</td><td>30</td><td>116</td></tr><tr><td>28</td><td>27</td><td>65.8</td><td>26</td><td>111</td></tr><tr><td>29</td><td>19</td><td>77.6</td><td>31</td><td>159</td></tr><tr><td>30</td><td>21</td><td>58.1</td><td>24</td><td>110</td></tr><tr><td>31</td><td>44</td><td>76.2</td><td>24</td><td>93</td></tr><tr><td>32</td><td>20</td><td>58.4</td><td>25</td><td>93</td></tr><tr><td>33</td><td>33</td><td>59.2</td><td>28</td><td>117</td></tr><tr><td>34</td><td>41</td><td>59.8</td><td>27</td><td>120</td></tr><tr><td>35</td><td>28</td><td>54.9</td><td>23</td><td>114</td></tr><tr><td>36</td><td>28</td><td>79.4</td><td>28</td><td>132</td></tr><tr><td>37</td><td>18</td><td>64.9</td><td>26</td><td>157</td></tr><tr><td>38</td><td>18</td><td>67.6</td><td>25</td><td>109</td></tr><tr><td>39</td><td>32</td><td>61.0</td><td>27</td><td>157</td></tr><tr><td>40</td><td>20</td><td>87.0</td><td>43</td><td>126</td></tr><tr><td>41</td><td>21</td><td>51.5</td><td>23</td><td>83</td></tr><tr><td>42</td><td>31</td><td>81.6</td><td>29</td><td>116</td></tr><tr><td>43</td><td>29</td><td>72.1</td><td>31</td><td>158</td></tr><tr><td>44</td><td>21</td><td>95.3</td><td>31</td><td>118</td></tr><tr><td>45</td><td>28</td><td>74.2</td><td>28</td><td>123</td></tr><tr><td>46</td><td>22</td><td>79.6</td><td>27</td><td>154</td></tr><tr><td>47</td><td>20</td><td>70.5</td><td>26</td><td>126</td></tr><tr><td>48</td><td>28</td><td>79.5</td><td>26</td><td>119</td></tr><tr><td>49</td><td>19</td><td>60.9</td><td>24</td><td>73</td></tr><tr><td>50</td><td>20</td><td>77.6</td><td>27</td><td>116</td></tr></table>  

(a) 进行适当的分析，以量化直接测量和间接测量收缩压之间的一致性。  
(a) Carry out an appropriate analysis to quantify the agreement between the directly and indirectly measured systolic blood pressures.  

(b) 利用来自   
(b) Using the results from   
(a) 的结果，对于多大比例的女性，会  
(a), for what proportion of women would  

两种方法之间的差异是否预期在 $10 \mathrm{mmHg}$ 以内？  
the difference between the methods be expected to be within  $10 \mathrm{mmHg}$ ？  

(c) 差异与体重、臂围或年龄之间是否存在任何关系？  
(c) Is there any relation between the differences and weight, arm circumference or age？  

(d) 上表显示了女性受试者研究时的顺序数据。下表显示了每10名女性为一组，其间接-直接收缩压差异的均值和标准差：  
(d) The above table shows the data in the order in which the women were studied. The following table shows the mean and standard deviation of the indirect-direct differences in systolic blood pressure for the women taken in blocks of 10:  

<table><tr><td rowspan="2">女性</td><td colspan="2">SBP差异 (mm Hg)</td></tr><tr><td>均值</td><td>标准差</td></tr><tr><td>1–10</td><td>-12.3</td><td>14.0</td></tr><tr><td>11–20</td><td>-4.7</td><td>11.1</td></tr><tr><td>21–30</td><td>-5.2</td><td>9.1</td></tr><tr><td>31–40</td><td>-1.8</td><td>14.3</td></tr><tr><td>41–50</td><td>0.0</td><td>11.8</td></tr><tr><td>总计</td><td>-4.8</td><td>12.5</td></tr></table>  
<table><tr><td rowspan="2">Women</td><td colspan="2">Difference in SBP (mm Hg)</td></tr><tr><td>Mean</td><td>SD</td></tr><tr><td>1–10</td><td>-12.3</td><td>14.0</td></tr><tr><td>11–20</td><td>-4.7</td><td>11.1</td></tr><tr><td>21–30</td><td>-5.2</td><td>9.1</td></tr><tr><td>31–40</td><td>-1.8</td><td>14.3</td></tr><tr><td>41–50</td><td>0.0</td><td>11.8</td></tr><tr><td>Total</td><td>-4.8</td><td>12.5</td></tr></table>  

什么可能解释SBP平均差异的变化？  
What might explain the variation in the mean difference in SBP？  

(e) 重复   
(e) Repeat   
(a) 和   
(a) and   
(b)，排除前十名女性，并将结果与针对所有50名女性获得的结果进行对比。  
(b) excluding the first ten women and contrast the answers with those obtained for all 50 women.  

16.7 作为一项急性高原反应研究的一部分，一支东非登山探险队的15名成员在快速攀升至 $4300 \mathrm{m}$ 前后进行了血浆醛固酮测量（Milledge et al., 1989）。下表显示了三天内09:00在低海拔和高海拔地区进行的测量结果，以及急性高原反应（AMS）的症状评分—高值表示症状更严重。  
16.7 As part of a study of acute mountain sickness fifteen members of a climbing expedition to East Africa had plasma aldosterone measurements taken before and after a rapid ascent to  $4300 \mathrm{m}$  (Milledge et al., 1989). The following table shows measurements taken at 09.00 at low and high altitudes over three days, together with a symptom score for acute mountain sickness (AMS) - high values mean worse symptoms.  

<table><tr><td rowspan="2">受试者</td><td rowspan="2">AMS评分</td><td rowspan="2">低   
<table><tr><td rowspan="2">Subject</td><td rowspan="2">AMS score</td><td rowspan="2">Low   
第1天</td><td colspan="2">血浆醛固酮（mmol/l）</td></tr><tr><td>高   
Day 1</td><td colspan="2">Plasma aldosterone (mmol/l)</td></tr><tr><td>High   
第2天</td><td>高   
Day 2</td><td>High   
第3天</td></tr><tr><td>1</td><td>1</td><td>68</td><td>151</td><td>188</td></tr><tr><td>2</td><td>1</td><td>153</td><td>49</td><td>77</td></tr><tr><td>3</td><td>7</td><td>110</td><td>141</td><td>95</td></tr><tr><td>4</td><td>9</td><td>238</td><td>286</td><td>143</td></tr><tr><td>5</td><td>11</td><td>204</td><td>242</td><td>84</td></tr><tr><td>6</td><td>11</td><td>141</td><td>263</td><td>63</td></tr><tr><td>7</td><td>11</td><td>183</td><td>233</td><td>121</td></tr></table>  
Day 3</td></tr><tr><td>1</td><td>1</td><td>68</td><td>151</td><td>188</td></tr><tr><td>2</td><td>1</td><td>153</td><td>49</td><td>77</td></tr><tr><td>3</td><td>7</td><td>110</td><td>141</td><td>95</td></tr><tr><td>4</td><td>9</td><td>238</td><td>286</td><td>143</td></tr><tr><td>5</td><td>11</td><td>204</td><td>242</td><td>84</td></tr><tr><td>6</td><td>11</td><td>141</td><td>263</td><td>63</td></tr><tr><td>7</td><td>11</td><td>183</td><td>233</td><td>121</td></tr></table>  

<table><tr><td rowspan="2">受试者</td><td rowspan="2">AMS评分</td><td colspan="3">血浆醛固酮（mmol/l）</td></tr><tr><td>低   
<table><tr><td rowspan="2">Subject</td><td rowspan="2">AMS score</td><td colspan="3">Plasma aldosterone (mmol/l)</td></tr><tr><td>Low   
第1天</td><td>高   
Day 1</td><td>High   
第2天</td><td>高   
Day 2</td><td>High   
第3天</td></tr><tr><td>8</td><td>13</td><td>119</td><td>245</td><td>97</td></tr><tr><td>9</td><td>13</td><td>272</td><td>275</td><td>115</td></tr><tr><td>10</td><td>14</td><td>166</td><td>241</td><td>150</td></tr><tr><td>11</td><td>15</td><td>228</td><td>109</td><td>76</td></tr><tr><td>12</td><td>17</td><td>77</td><td>192</td><td>63</td></tr><tr><td>13</td><td>18</td><td>114</td><td>46</td><td>43</td></tr><tr><td>14</td><td>23</td><td>91</td><td>189</td><td>74</td></tr><tr><td>15</td><td>35</td><td>105</td><td>254</td><td>283</td></tr></table>  
Day 3</td></tr><tr><td>8</td><td>13</td><td>119</td><td>245</td><td>97</td></tr><tr><td>9</td><td>13</td><td>272</td><td>275</td><td>115</td></tr><tr><td>10</td><td>14</td><td>166</td><td>241</td><td>150</td></tr><tr><td>11</td><td>15</td><td>228</td><td>109</td><td>76</td></tr><tr><td>12</td><td>17</td><td>77</td><td>192</td><td>63</td></tr><tr><td>13</td><td>18</td><td>114</td><td>46</td><td>43</td></tr><tr><td>14</td><td>23</td><td>91</td><td>189</td><td>74</td></tr><tr><td>15</td><td>35</td><td>105</td><td>254</td><td>283</td></tr></table>  

(a) 对三天内的血浆醛固酮水平进行适当的分析。哪些天对之间存在显著差异？  
(a) Carry out an appropriate analysis of the plasma aldosterone levels on the three days. Which pairs of days are significantly different？  

(b) 获取第1天和第2天血浆醛固酮水平差异的 $95\%$ 置信区间。  
(b) Obtain a  $95\%$  confidence interval for the difference between plasma aldosterone levels on days 1 and 2.  

(c) 检查AMS评分与第1天和第2天之间血浆醛固酮变化的关系。  
(c) Examine the association between the AMS score and the change in plasma aldosterone between days 1 and 2.  

16.8 针对一项比较麸皮饼干与安慰剂饼干在肠易激综合征患者饮食中效果的交叉临床试验分析所受到的批评，第一作者写道：  
16.8 In response to the criticism of the analysis of a crossover clinical trial of bran biscuits versus placebo biscuits in the diet of patients with irritable bowel syndrome, the first author wrote:  

“然而，在我们这样的研究中，考虑到样本量相对较小，置信区间……很可能包含零，范围相当宽，并且包含正值和负值。因此，这不适合采用这种形式的分析，因为结果总是过于分散而失去意义。”  
'In studies such as ours, however, given the relatively small numbers, a confidence interval … is likely to contain zero, be fairly wide and include both positive and negative values. Therefore this is not an appropriate setting for this form of analysis as the result always will be too diffuse to be meaningful'  

(Lucey, 1987)。  
(Lucey, 1987).  

这是一个合理的论点吗？  
Is this a reasonable argument？  
